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ABSTRACT
CHARACTERIZATION OF MURINE CYTOMEGALOVIRUS m l42 AND ml43
ESSENTIAL GENE PRODUCTS
Bridget Dalton
Eastern Virginia Medical School and Old Dominion University, 2001
Director: Dr. Ann Campbell
Cytomegalovirus (CMV) is a species-specific virus belonging to the
Herpesviridae family. This DNA virus causes severe disease or even death in
newborns and immunosuppressed patients. Murine CMV (MCMV) provides an
opportunity to study the role of various viral products in replication and pathology in
the natural host. Successful replication of CMV in the host depends upon the
expression o f a cascade o f viral genes: immediate early (IE), early (E), and late (L). To
date only three MCMV IE proteins have been characterized (IE1, IE2 and IE3). Our
laboratory recently identified a novel IE gene region within the Hind III I region of
MCMV. These genes, m l42 and m l43, are members o f the US22 gene family of
HCMV, some o f which are transcriptional transactivators. The m l42 and m l43 genes
are also essential for viral replication in fibroblasts.
The purpose of this dissertation was to characterize the m l42 and m l43
transcripts and proteins, as well as determine if the gene products function as
transcriptional transactivators like some of the other US22 gene family members.
Although the m l42 and m l43 transcripts were present during IE times, levels o f these
two transcripts increased during early times o f viral infection and remained abundant
during late times. The genes, m l42 and ml43, encode a 1.8 and 3.8 kb transcript,
respectively. The m l42 and m l43 proteins (designated pm l42 and pm l43,
respectively) encoded by these transcripts were present by 3 hours post infection and
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remained abundant at 12 and 24 hours post infection. Interestingly, pm 142 and pm 143
could not be designated as immediate early proteins, because they were not expressed
in the presence o f drugs that block viral growth at this specific stage within the viral
replication cycle. Therefore, the m l42 and m l43 immediate early genes do not
express detectable levels o f protein until early times post infection. The pm 142 protein
is 43 kD protein, and the pm l43 protein is 53 kD. The pm l42 and pm 143 proteins
localized to both the nucleus and the cytoplasm at 3, 4 and 24 hours post infection.
In transactivation studies, we tested the ability o f pm 142 and pm 143 to activate
the MCMV major immediate early promoter (M122-123) and the early el promoter
(M l 12-113). In combination, MCMV pm l42 and pml43 transactivated the MCMV
major immediate early promoter and enhancer (MIEPE) in a dose dependent manner
to at least 3 fold above basal levels. However, individually pm l42 or pm l43 failed to
transactivate the MIEPE. Together, pm l42 and pml43 also exhibited noncooperative
effects with IE1 and IE3 in the activation o f the MCMV MIEPE. In combination,
p m l42 and pml43 failed to activate the early e l promoter, but pm l42 and pml43
cooperated with IE 1 and IE3 to activate this promoter. Activation o f the e 1 promoter
by IE1 and IE3 increased from 30 fold above basal levels in the absence of pm l42 and
pm l43, to as high as 100 fold above basal levels in the presence o f pm l42 and pml43.
This was the first time it has been shown that other MCMV viral proteins assist in
IE1/IE3 mediated transactivation o f the e l promoter or any other promoter, and these
findings have important implications in MCMV replication.
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CHAPTER I
INTRODUCTION
Cyto megalo viruses
The cytomegaloviruses are members o f the herpesvirus family. They share many
characteristics with the other herpesviruses such as virion and genome structure and the
ability to establish latent and persistent infection (reviewed in Mocarski, 1996).
Cytomegaloviruses infect a wide variety o f host species including rodents, domestic
animals, and primates (Plummer, 1973). The cytomegaloviruses have several
distinguishing characteristics. They are highly species specific, display a tropism for the
salivary gland, have a relatively long replication cycle, and produce cell enlargement with
intranuclear inclusions (Roizman et al., 1981).

Cytomegalovirus Associated Disease
In North America, the prevalence o f human cytomegalovirus (HCMV) infection
is about 50% o f the population in rural areas (reviewed in Mocarski, 1996). In major
cities, the prevalence o f cytomegalovirus infection is up to 90% (Mocarski, 1996). In
immunocompetent individuals, HCMV infection is usually mild or asymptomatic.
However, the virus persists in the host for life in a latent s^ate, with episodes of
spontaneous reactivation. The vims can cause severe disease, and even death in those
individuals with suppressed immune systems. Therefore individuals that are at high risk
for HCMV disease include the very young, such as the developing fetus or newborn, as
well as patients undergoing immunosuppressive therapy for either cancer or organ

The model journal for this dissertation is Virology.
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transplantation, or those with immunodeficiency diseases such as AIDS (Mocarski,
1996).
Approximately 0.5-1% o f all newborns are bom infected with HCMV. However,
only one out o f ten of these infants demonstrate symptoms at birth. The clinical
manifestations o f congenital HCMV include brain damage, mental retardation, ocular
damage, hepatic disease and pneumonia. Neurologic damage is a symptom o f severe
disseminated disease (Fjaer et al., 1997; Ahlfors et ah, 1999; Dahle et al., 2000; Coats et
al., 2000).
Cytomegalovirus is the most important infectious agent affecting organ and bone
marrow transplant recipients. At least two-thirds of organ transplant and bone marrow
recipients exhibit evidence o f HCMV infection within 1-4 months after transplantation
(Rubin, 1990; Zaia, 1993; Costa et al., 1999). More serious disease occurs when
seronegative recipients receive organs from a seropositive donor, since a primary HCMV
infection ensues under conditions in which the transplant recipient may be
immunosuppressed. HCMV is also associated with decreased graft survival. It is
proposed that rejection o f the graft is due to a viral-induced increase in the expression of
MHC antigens within the graft, predisposing the graft to rejection. Alternatively
molecular mimicry could explain host mediated graft rejection o f the infected organ. In
this case, HCMV proteins with homology to MHC class 1 molecules within the organ
induce an immune response against the transplanted organ (Mocarski, 1996; Borchers et
al., 1999). Transplant recipients with HCMV develop a wide variety o f clinical diseases.
These include prolonged fevers, leukopenia, thrombocytopenia, atypical lymphocytosis
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and elevated hepatic transaminases. Severe HCMV infections are associated with
gastrointestinal problems, hepatitis and pneumonia (Ho, 1991).
HCMV is also one o f the most important opportunistic infections encountered in
AIDS patients. About 90% o f AIDS patients develop HCMV infection, and up to 40%
may develop vision and/or life threatening HCMV induced disease (Gallant et al., 1992).
The most common manifestations of disease include encephalitis, retinitis, colitis and
CMV pneumonitis (Roullet, 1999; Chakraborty, 1999; Soloman and Perlman, 1999) .
The link between HCMV and AIDS could be due to molecular interactions between HIV
and HCMV. The HIV long terminal repeat is transcriptionally activated by the HCMV
major immediate early (IE) proteins, and HCMV replication is enhanced by the presence
o f active HIV infection (Rando et al., 1990; Walker et al., 1992; McCarthy et al., 1998;
Yurochko et al., 1999). However to date, the role o f HCMV in AIDS is poorly
understood.

Cytomegalovirus Pathogenesis
HCMV is usually spread by direct or indirect person to person contact (reviewed
in Mocarski, 1996). Sources of the virus include the saliva, urine, cervical and vaginal
secretions, semen, breast milk, tears, feces and blood. In individuals with severe
disseminated HCMV, virtually all organ systems may be affected. However, the salivary
gland, the genitourinary tract, the gastrointestinal tract, the respiratory tract, the central
nervous system, and the liver are sites commonly involved in HCMV infections of
immunosuppressed individuals. In individuals with a normal immune system, no clinical
evidence o f infection occurs. However, the virus remains associated with the individual
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for life, either as an asymptomatic productive infection or in a latent state (Mocarski,
1996).
Cellular immune responses are important in curtailing the virus infection and
maintaining the virus-host equilibrium in persistent HCMV infection (Alp et al., 1991).
Natural killer cells are activated early after viral infection and are a part o f the non
specific immune response. During this time, interferon alpha/beta are produced by
macrophages, and they represent another non-specific antiviral defense mechanism. Cell
mediated immunity involving CD4+ and CD8+ T lymphocytes are responsible for
clearing the virus from target organs. The HCMV immediate early 1 (IE1) protein is a
target for CD8+ T cells in humans (Alp et al., 1991), as is the equivalent IE1 protein in
mice (Reddehase et al., 1987). Several late HCMV proteins are also the target o f specific
cytotoxic T cell responses. These proteins include pp65, gB, ppl50 and pp28
(McLaughlin-Taylor et al., 1994; Hopkins et al., 1996; Li et al., 1997; Gyulai et al.,
2000). HCMV IE1 also contains several immunodominant polypeptides, which elicit an
antibody response against HCMV (Landini and La Placa, 1991). The CD4+ T cells are
important helper cells for antibody and CD8+ responses (Alp et al., 1991). Antibodies
may control systemic spread of recurrent infections following reactivation, however they
do not participate in clearing virus from target organs (Landini and La Placa, 1991).
HCMV infects several different cell types. These include epithelial, endothelial,
mesothelial, fibroblast, and glial cells (Sinzger et al., 1993). Leukocytes circulating in
the peripheral blood are also susceptible to CMV infection (Sinzger et al., 1996) and
these cells play a central role in viral pathogenesis. More specifically, the monocyte
precursor cell or CD34+ bone marrow progenitor cell has been shown to harbor HCMV
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DNA in the form of a circular plasmid (Bolovan-Fritts et al, 1999), under conditions in
which transcription from the viral genome is limited. However when these cells are
allowed to differentiate in culture, infectious virus can be recovered. Therefore in vivo,
the CD34+ bone marrow progenitor cell serves as a reservoir o f latent virus and also as a
vehicle for disseminating the virus to target organs (Maciejewski et al, 1992; Mendelson
et al., 1996; Maciejewski and St Jeor, 1999). The CD34+ cells differentiate into CD33+
cells. Latent infection, the expression o f latency associated transcripts, and reactivation
o f virus upon cellular differentiation has also been demonstrated in cells coexpressing
CD33 and CD 15 or CD33 and CD 14 along with dendritic cell markers (Hahn et al,
1998).
During latency, HCMV viral gene expression is restricted such that only
immediate early transcripts are detected. The immediate early transcripts expressed
during latency originate from a single locus, the major immediate early gene locus. Two
genes are expressed from this locus during latency (iel and ie2); however, these
transcripts differ significantly from those present during a productive infection. Latent
transcripts called sense transcripts are encoded in the same direction as productive phase
transcripts but use novel start sites in the HCMV iel/ie2 promoter region. Other latent
transcripts called antisense transcripts are unspliced and are complementary to exons
within iel. Antibody to the proteins encoded by these transcripts are detectable in the
serum o f seropositive individuals implying that protein products are synthesized from
these transcripts during latent or productive infection (Kondo et al., 1994; Kondo and
Mocarski, 1996; Landini et al., 2000).
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Factors that cause the latently infected monocyte precursor cell to differentiate
into a fully permissive macrophage contribute to HCMV reactivation. When myeloid
progenitor cells are experimentally infected, HCMV can be reactivated when these cells
are cultured in the presence o f interferon gamma, tumor necrosis factor alpha (TNFa),
interleukin-4 (IL-4) or granulocyte-macrophage-colony-stimulating factor (GM-CSF)
(Hahn et al., 1998). These cells can also reactivate when cultured in the presence of
fibroblasts or fibroblast conditioned medium. Naturally infected macrophage progenitor
cells can reactivate latent HCMV when allogeneically stimulated. The cytokine
interferon-gamma, but not IL-4, TNF or GM-CSF, is essential for reactivation in these
cells (Soderberg-Naucler et al., 1998). Therefore, there are differences between
experimentally and naturally infected cells.
The murine model has been used to address the role that monocytes and
macrophages play in the pathogenesis o f cytomegalovirus infection. Since CMV is
species specific, MCMV infection offers the opportunity to study CMV disease,
protection against it, and conditions for establishing persistent and latent infection in the
natural host. In the mouse model, the macrophage progenitor cell not only is one of the
first cell types to support MCMV replication during infection, but macrophages also
disseminate the vims to the spleen, lung, and liver, and harbor latent MCMV DNA
(Collins et al., 1993; Stoddart, 1994; Pollock and Virgin, 1995; Koffron et al., 1998).
On the other hand, the infected macrophage triggers the early innate immune response
by producing monokines like interferon alpha/beta, TNF alpha, and IL-12. Interferon
alpha leads to the activation of NK cells, which produce interferon gamma. Interferon
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gamma activates macrophages which makes them less permissive and limits viral gene
expression, and along with IL-12 activates CTLs (Hanson et al., 1999).
As stated previously, monocyte progenitor cells are a source of latent CMV and
also serve as a source o f CMV dissemination and reactivation (Zhuravskaya et al., 1997).
During latency, monocytes harbor viral DNA; however, the presence of infectious virus
can not be detected. In mice, macrophages that are latently infected with MCMV contain
as many as 10 copies o f the MCMV genome per cell. When the latently infected
monocyte is cocultured with murine embryonic fibroblast cells, infectious virus is
reactivated (Pollock et al., 1997). Latency has been observed in the heart, kidney, liver,
lung, spleen, brain, and salivary glands of mice (Collins et al., 1993, Reddehase et al.,
1994).
During latency in the lung, transcription from the MCMV major immediate early
promoter occurs (Kurz et al., 1999; Kurz and Reddehase, 1999). Under these conditions
transcription is restricted to iel, while the ie3 transcript equivalent to ie2 of HCMV is
absent. The transcription o f iel in the lung tissue during latency is focal and randomly
distributed, although the viral genome is evenly distributed throughout the entire organ.
Foci that express iel may be progressing through several sequentially ordered control
points that when passed, will lead to recurrence (Kurz et al., 1999; Kurz and Reddehase,
1999). The switch from iel to ie3 precursor mRNA transcriptional processing may
trigger this transition. During recurrence, iel transcription in the lung is generalized, and
the ie3 transcript is present (Kurz et al., 1999; Kurz and Reddehase, 1999).
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The Viral Genome
Human CMV has a very large genome, o f over 230 kilobase pairs, encoding over
230 genes (Chee et al., 1990). These genes are numbered sequentially within the viral
genome. The genome is arranged in a very complex manner, containing internal
reiterated sequences that enable the virus double-stranded DNA to arrange in four
genomic isomers. For example, HCMV has sequences from both termini that are
repeated in an inverted orientation and juxtaposed internally dividing the genome into a
unique long region and a unique short region (UL and US), each flanked by internal
repeats. The unique long region o f HCMV is flanked by terminal repeat sequences
(TRL) and internal repeat sequences (IRL). Likewise, the unique short region o f the
virus is flanked by terminal repeat sequences (TRS) and internal repeat sequences (IRS)
(Jahn and Sinzger, 1996). HCMV genes are named according to their location within the
repeat sequences or unique regions o f the viral genome as well as their number within the
HCMV genome (ex. U L 112).
In HCMV the unique components can invert relative to each other during
replication giving rise to the four genomic isomers. Virally infected cells can contain any
one o f the four isomers and each isomer is present at equimolar concentrations (Oram et
al., 1982). The MCMV genome however, consists primarily of unique sequences with
few repeat sequences. Therefore, no isomers are present in the murine strain. Although
the HCMV and MCMV genomes have been completely sequenced, analysis o f individual
gene function is incomplete. However, HCMV and MCMV genes are characterized as
either essential or non-essential for viral growth in cultured cells. Essential genes are
those required for virion structure and vims replication in tissue culture, whereas non
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essential genes are those not required for virus growth in cell culture but may be involved
in virus/host interactions in vivo (Mocarski et al., 1990).

The Virion Structure
CMV has an icosahedral virion structure containing the double stranded DNA
genome, and is surrounded by a tegument. These components are packaged in a lipid
bilayer envelope containing virally encoded glycoproteins (Wright et al., 1964).
The CMV capsid contains seven proteins. These proteins include the
major capsid protein (UL86), the minor capsid protein (UL85), the minor capsid binding
protein (UL46), the smallest capsid protein (UL48.5), and three distinct
assemblin/assembly proteins (UL80.5, UL80, and UL80a). These proteins make up the
structure o f the capsid or are involved in capsid assembly (Mocarski, 2000).
An array o f fibrous, granular proteins called tegument proteins are interfaced
between the capsid and the envelope. There are 25 tegument proteins and most o f these
proteins are phosphorylated and denoted by the prefix "pp". The function o f most
tegument proteins is unknown. However, several have been shown to function as
transcriptional transactivators (Mocarski, 2000). For example, HCMV pp71 (UL82) is a
tegument protein, which activates HCMV IE gene expression and increases the
infectivity o f HCMV DNA (Lui and Stinski, 1992; Baldick et al., 1997; Chau et al.,
1999). Recently, several HCMV transcripts called virion RNAs were found to be
packaged within the virion (Bresnahan and Shenk, 2000). The function o f the putative
proteins encoded by these transcripts is unknown (Bresnahan and Shenk, 2000).

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

10

The viral envelope is composed o f a lipid bilayer membrane containing eight
virally encoded glycoproteins. The viral envelope contains two prominent glycoprotein
complexes. One is composed o f dimers o f gB (UL55), and the other is composed o f gH,
gL and gO (UL75, UL115, and UL74) (Mocarski, 2000). Several o f these glycoproteins
are highly conserved among the herpesviruses (gB, gH, gL, and gM ). These proteins are
involved in virion attachment, penetration, transmission from cell to cell, and fusion of
infected cells (Britt and Mach, 1996). These proteins, in particular glycoprotein gB, are
also targets o f the host humoral immune response (Navarro et al., 1997). The envelope o f
CMV renders this vims sensitive to low pH, lipid solvents and heat; accordingly, virions
have a half life o f approximately 60 minutes at 37 degrees Celsius (Vonka and BenyeshMelnick, 1966).

Cytomegalovirus Attachment/Penetration
The initial event in the viral replication cycle is viral attachment. During viral
attachment, the viral envelope protein gB binds to cell surface heparin sulfate (Compton
et al., 1993; Navarro et al., 1993; Boyle and Compton, 1998). T he initial interaction
with heparin sulfate is followed by a more specific interaction between the vims and a
cellular receptor. The cellular receptor that mediates this event is unknown. It was
proposed that a 30-36 kDa gB-binding cell surface protein is involved in attachment.
However when this protein, which has been identified as annexin II, was blocked with
annexin II specific antibodies, viral entry was not hampered. These experiments suggest
that annexin II is not the true molecule involved in CMV attachment and penetration
(Pietropaolo and Compton, 1999).
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After the virus particle has attached to the cell surface, penetration occurs within 5
minutes (Bodaghi et al., 1999). HCMV penetrates the host cell in a pH independent
manner mediated by fusion between the viral envelope and the host cell plasma
membrane. This event likely involves the complex o f envelope glycoproteins gH, gL and
gO (Compton et al., 1992). Following viral entry, the viral nucleocapsids enter the
nuclear pores and deliver the viral DNA to the nucleus for expression (Bodaghi et al.,
1999).

Cytomegalovirus Replication
Cytomegalovirus genes are expressed in three sequential phases: immediate early,
early, and late. Immediate early gene expression does not require de novo protein
synthesis. The immediate early gene products activate the expression o f the early genes
and serve to autoregulate their own expression. The early genes encode proteins involved
in DNA replication; for example the DNA polymerase, the DNA polymerase accessory
protein, and the helicase/primase complex. Other early genes are not required for viral
DNA replication, but are involved in viral pathogenesis, tissue tropism and immune
evasion. Late genes encode structural proteins involved in packaging the viral genome,
such as the tegument proteins and the envelope glycoproteins (Mocarski, 1996).
Drugs have been used to define the three classes o f CMV genes expressed in an
infected cell. The drugs anisomycin and cycloheximide prevent protein synthesis,
thereby allowing expression o f only the immediate early genes from a CMV infected cell.
Gancyclovir and phosphonoacetic acid prevent viral DNA replication by causing
premature nucleic acid chain termination and inhibition o f the activity o f the viral DNA
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polymerase. Therefore the replication cycle is blocked at the expression of the early
genes. Late genes are those that are expressed following viral DNA replication. These
genes are expressed when the viral genome is allowed to replicate completely in the
absence o f drug inhibitors.
Recently DNA microarray technology has been used to study the three classes of
viral genes expressed from CMV infected cells. This system allows all HCMV genes to
be studied simultaneously. Briefly, a DNA microarray containing sequences from each
individual viral open reading frame was printed on glass slides. These viral
oligonucleotides were then analyzed in a single hybridization step using flourescently
labeled cDNA from virally infected cells as a probe. The viral cDNA was obtained from
cells that had been treated with the drug inhibitors mentioned previously. The results
displayed a temporal map o f both known and previously unknown immediate early (IE),
early (E), and late (L) genes o f the entire HCMV genome. Since this system allows the
study o f over 200 genes in a single experiment, it is particularly important when studying
large viral genomes like those in HCMV (Chambers et al., 1999).
In MCMV, immediate early genes are expressed 0-3 hours post infection, early
genes are expressd 3-12 hours post infection and late genes are expressed 12-24 hours
post infection (Keil et al., 1984; Messerle et al., 1991; Messerle et al., 1992). HCMV
replication occurs much slower than MCMV replication. The immediate early genes are
expressed 0-24 hours, early genes are expressed 24-48 hours and late genes are expressed
48-72 hours post infection.
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HCMV Major Immediate Early Genes
There are five regions within the HCMV genome that are transcribed at
immediate early times. These include UL36-38, UL122-123, TRS1-IRS1, UL69 and
US3. The majority of the IE transcripts arise from the U L122-123 locus and are referred
to as major immediate early proteins (Fig. 1). The major immediate early genes are
designated by lower case letters (ex. iel), while the major immediate early proteins are
designated by upper case letters (ex. IE1). Two immediate early proteins (IE55 and
IE 18) are expressed at low levels by differential splicing from this region and likely
influence cell type specificity. Two predominant proteins also originate from this gene
region by differential splicing, the 72 kDa EE1 protein and the 86kDa IE2 protein (Stinski
et al., 1983; Stenberg et al., 1984; Stenberg et al., 1985; Stenberg et al., 1989; Kerry et
al., 1995). The IE1 and IE2 gene products have been implicated in the positive regulation
o f viral gene expression (Stenberg et al., 1990). IE I activates expression of the IE1/IE2
enhancer (Stenberg et al., 1990). IE1/IE2 is also required for DNA replication by
functioning to activate early proteins required for DNA synthesis (Kerry et al., 1994,
Kerry et al., 1996). In addition to its ability to autostimulate its own synthesis, IE1
cooperates with IE2 in the activation of subsequent kinetic classes of gene expression
(Stenberg et al., 1996; Colberg-Poley et al., 1992; Fortunato and Spector, 1999). For
example, although the UL112-113 promoter is efficiently transactivated by IE2 alone,
this activation is augmented by IE1 (Colberg-Poley et al., 1992). IE2 is involved in the
shut off of IE1/IE2 gene expression (Stenberg et al., 1990), thought to occur by direct
DNA binding to the cis repression sequence (crs). The crs spans the IE 1/2 promoter CAP
site (Lang and Stamminger, 1993), and IE2 binding interferes with assembly of the
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LTL122-123.

Human CMV
169367

-CD
172783

IE72 (IE1)
IE86 (IE2)
IE55
IE18
M 122-123

Murine CMV
177009'

**• 181933

iel (IE1)
ie3 (IE3)
ie2 (IE2)

FIG. 1. Structural organization o f the human and murine CMV major
immediate early gene loci. The HCMV IE early gene region (U L 122-123)
is located between HCMV sequences 169367-172783. There are four IE
mRNAs originating from this region by differential splicing. The MCMV IE
gene region (M l 12-113) is located between MCMV sequences 177009-181933.
There are three IE mRNAs originating from this region by differential splicing.
The arrows depict transcripts, with the exon number underneath. The black
boxes represent the enhancer region (Stenberg et al., 1989; Kerry et al., 1995;
Keil et al., 1987). The bold numbers denote the name of the IE protein products.

preinitiation complex (Wu et al., 1993). IE2 is also a promiscuous transactivator o f
cellular genes, especially when used in conjunction with IE I (Stenberg et al., 1990). IE2
upregulates the hsp70, c-fos and c-myc promoters but transactivation by IE1 and IE2
together is synergistic (Hagemeier et al., 1992).
The expression of the HCMV immediate early proteins is controlled by a very
strong and complex enhancer (iel/ie2 enhancer) (Fig. 2). This enhancer is active in a cell
type and tissue specific manner. In transgenic mice containing the LacZ gene under the
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F IG 2. The upstream regulatory domains within the HCMV MIEP. A very
strong and complex enhancer controls the expression of the HCMV immediate
early genes, and this enhancer is active in a cell type and tissue specific manner.
The activity o f this promoter is driven by a wide variety of cellular transcription
factor binding sites present within the enhancer region. The promoter (pro),
enhancer, NF1 and modulator regions are denoted by bidirectional arrows. The
transcription factor binding sites are denoted by arrowheads and the region on
the promoter to which they bind has been mapped. (Mocarski, 1996).

control o f the HCMV major immediate early promoter, expression o f LacZ was found in
19 out o f 29 tissues. These tissues include the brain, eye, spinal cord, esophagus,
stomach, pancreas, kidney, bladder, testes, ovary, spleen, salivary gland, thymus, bone
marrow, skin, cartilage and muscle. Distinct cell types within these tissues expressed
LacZ. These cell types include retinal cells o f the eye, ductile cells of the salivary gland,
exocrine cells o f the pancreas, mucosal cells o f the stomach and intestine, neuronal cells
of the brain, muscle fibers, thecal cells o f the corpus luteum, and Leydig and sperm cells
of the testes (Baskar et al., 1996). The level o f differentiation of the infected cell also
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influences the activity o f this enhancer (Stamminger et al., 1990; Stein et al., 1993; Chan
etal., 1996; Baskaretal., 1996; Shering et al., 1997).
The strength of the HCMV ie l/ie2 enhancer can be attributed to a wide variety of
cellular transcription factor binding sites present within the DNA sequence. These
transcription factors include CREB/ATF, AP-1, NFkB, SP1, serum response factor and
NF1 (Mocarski, 2000). These factors bind to repeat elements, which are referred to by
their size (16-, 18-, 19- and 21- bp repeats). The transcription factor YY1 binds to a
region in the MIEP called the modulator. YY1 seems to modulate expression from this
enhancer by either acting as a repressor or as an activator of transcription (Lui et al.,
1994). The modulator however, is not necessary for the transcription o f the HCMV IE
genes (Meier and Stinski, 1997).
In order to determine the importance o f this enhancer, HCMV mutant viruses
have been made in which the HCMV major immediate early enhancer has been deleted.
Results indicate that the deletion o f the enhancer impairs virus growth in human
fibroblasts severely at a low multiplicity o f infection (MOI). However, at a high MOI,
viral growth in human fibroblasts is not inhibited when the MIEP is deleted. Therefore
the MIEP is important in augmenting viral IE gene expression under conditions in which
few viral DNA copies are present (Meier and Pruessner, 2000).
A HCMV IE1 mutant virus has also been made. This virus is deleted o f exon 4 of
IE I. In vitro, this virus is unable to replicate in human fibroblast cells at a low MOI. At
a low MOI, the IE1 mutant virus also failed to form viral DNA replication compartments
and to express the DNA polymerase accessory protein (ppUL44) which is required for
viral DNA replication (Greaves and Mocarski, 1998). However, at an MOI of at least
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three plaque forming units, the virus is able to replicate at levels similar to wild-type
virus (Mocarski et al., 1996). At a high MOI, the IE1 mutant virus was likely able to
replicate due to the presence o f virion proteins which have the ability to compensate for
the lack o f LEI by transactivating the MIEP.

HCMV Ancillary IE Genes
All of the HCMV ancillary IE proteins also regulate gene expression and interact
cooperatively. UL36-38 and US3 immediate early gene products regulate gene
expression of the hsp70 promoter, and this expression was synergistically increased when
both US3 and UL36-38 were transfected together (Colberg-Poley et al., 1992). HCMV
US3 is also involved in immune evasion by blocking the transport o f MHC class 1 heavy
chains from the Golgi complex through the endoplasmic reticulum (Jones et al., 1996).
UL37 is a type 1 integral membrane N-glycoprotein, and is proposed to regulate nuclear
gene expression by cell signaling (Zhang et al., 1996). The IE proteins UL36-UL38,
IRS 1/TRS1, and U L 122-123 are required for HCMV ori Lyt DNA replication. These
proteins cooperatively regulate the expression of the early proteins involved in DNA
replication (Pari and Anders, 1993; Pari et al., 1993; Iskenderian et al., 1996; Kerry et al.,
1996).

HCMV Early Regulatory Genes
Early CMV genes are expressed prior to viral DNA replication and encode
enzymes required for viral DNA replication. The early proteins involved in DNA
replication have been identified due to their homology to herpes simplex virus type 1
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(HSV-1) genes which are essential for HSV-L replication (McGeoch et al., 1988; Wu et
ah, 1988). The HCMV early genes involved in viral DNA replication include the DNA
polymerase UL54, the polymerase-accessory protein UL44, the single-stranded DNA
binding protein UL57, and the proposed subunits o f the helicase-primase complex, UL70,
UL105 and UL101-102 (Kouzarides et al., 1987; Heilbronn et al., 1987; Anders and
Gibson, 1988; Martignetti, 1991; Ertl and Powell, 1992). The viral DNA polymerase
(UL54) shares extensive amino acid homology with the DNA polymerase of HSV-1. The
HCMV DNA polymerase is found associated with an additional polypeptide in virally
infected cells, the DNA polymerase accessory protein (UL44). This protein is the CMV
homolog o f the DNA polymerase accessory protein o f HSV-1 (Ertl and Powell, 1992).
The DNA polymerase accessory protein functions to stimulate DNA polymerase activity
by increasing the processivity o f the DNA polymerase enzyme (Ertl and Powell, 1992).
The single stranded DNA binding protein (UL57) binds to single stranded DNA and
anchors the polymerase to the replication complex (Anders et al., 1986). The helicase
complex (UL70, UL105 and U L 101-102) is involved in priming lagging strand synthesis
and unwinding DNA at the replication fork (Crute et al., 1989; Martignetti and Barrell,
1991). The sequence o f the CMV helicase complex is also similar to the helicase
complex o f HSV-1. The two remaining proteins, UL84 and UL112-UL113, encode
nuclear localized proteins. UL112-UL113 helps to regulate expression of the replication
fork proteins (Iskenderian, 1996; Kerry 1996), while UL84 is required for the formation
o f intranuclear replication compartments (Sarisky and Hayward, 1996; Yamamoto et al.,
1998).
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In order for the expression o f the viral DNA replication genes and subsequent
viral DNA replication to occur, the presence o f the immediate early proteins is necessary.
The immediate early proteins which are required to complement HCMV DNA replication
in transient transfection assays include UL36-38, IRS1/TRSI, and IE1 and EE2 (UL122123). These proteins are involved in regulating the expression o f the early genes required
for DNA replication, and they act synergistically in activating the expression of these
genes (Iskenderian et al., 1996, Kerry et al., 1996). Not only are the immediate early
genes important in activating the early gene promoters, but cellular factors play an
important role as well. The cellular proteins ATF-1 and SP-1 assist the immediate early
proteins in regulating the DNA polymerase promoter (Kerry et al, 1996; Kerry et al.,
1997; Luu and Flores, 1997). The cellular factors CREB and ATF are required for full
activation o f the US 11 and UL112-113 early promoters (Rodems et al., 1998; Chau et al.,
1999). The presence o f these cellular factors, which work in conjunction with the
immediate early proteins in activating viral early promoters, likely influence cell-specific
transactivation o f viral genes.

HCMV Late Genes
Following early gene expression, viral DNA is replicated in a rolling circle
mechanism that yeilds head to tail concatemers o f unit length DNA. Following DNA
replication, the late genes are expressed. These encode the structural proteins of the
virion (see Virion Structure). Since very few late genes have been studied, very little is
known about their regulation. The late gene pp65, which encodes the lower-matrix
phosphoprotein, has been studied in transient transfection assays. In these assays, the
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pp65 promoter is activated by the IE1 and IE2 proteins, and a 8-base pair sequence
appears to be important in the regulation o f this promoter (Depto and Stenberg, 1989).
The HCMV UL94 gene product, which encodes a virion protein, has been studied as
well. These studies indicate that a positive and negative regulatory region is present
within the UL94 promoter, and the cellular protein p53 plays a central role in regulating
this promoter (Wing et al., 1998). Functional analyses of the pp28 prom oter indicate that
a 10 base pair sequence is important for promoter activation. This suggests that viral or
cellular factors may act through these specific sequences to activate late gene expression
(Depto and Stenberg, 1992).

Viral Assembly And Egress
Following late gene expression, the viral DNA is processed into genome length
monomers and packaged in the viral capsids in the nucleus. Viral glycoproteins and
tegument proteins accumulate and form patches in the nuclear membrane. The capsids
then attach to a patch o f modified inner lamellae o f the nuclear membrane and become
enveloped (Radsak et al., 1990). Although the nuclear membrane is the initial site o f
envelopment, this coat is removed in the cytoplasm (de-envelopment). The virion is then
transported in vesicles through the Golgi to the cell surface (Eggers et al., 1992; Whiteley
et al., 1999). Re-envelopment occurs as the virion buds from the cellular membrane,
which is also modified by viral glycoproteins (Stinski et al., 1979). Therefore, egress
from the cell may follow the exocytic pathway although this has not been definitively
established and is still under investigation (Mocarski, 1996).
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MCMV As a Model For HCMV Disease
Due to the strict species specificity o f the cytomegaloviruses, murine
cytomegalovirus (MCMV) has been used as a model for human cytomegalovirus disease.
Human and murine cytomegaloviruses share several characteristics. They both contain a
large DNA genome o f approximately 230 kilobases in length. HCMV and MCMV also
have significant similarity in gene families, the presence o f short direct and internal
repeat sequences, and similar G and C content (particularly within the central part of the
genome). Furthermore, the central part o f the MCMV genome is colinear and generally
homologous to the HCMV genome. The MCMV genes with homology to HCMV are
indicated by the uppercase prefix M (ex. M l 12) while the MCMV genes with minimal
sequence similarity to HCMV are indicated by the lowercase prefix m (ex. m40).
The functions o f several MCMV gene products can be predicted based on
sequence homology with HCMV genes or have been proven based on functional assays
(Rawlinson et al., 1996). Finally, both viruses are biologically similar in terms o f tissue
tropism, latency and reactivation (Mocarski et al., 1990; Campbell, 1999).

MCMV Immediate Early Genes
To date only three MCMV immediate early genes have been characterized
(M122, m l23 and m l28). These are located between map units 0.769 - 0.817, a region
roughly colinear with the HCMV immediate early region (Kosinowski et al., 1986; Keil
et al., 1987a; Keil et al., 1987b; Messerle et al., 1991; Messerle et al., 1992; Cardin et al.,
1995). MCMV iel (m l23) and MCMV ie3 (M122) genes are expressed from the same
promoter from right to left and have a similar splicing pattern as the HCMV IE proteins
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(Fig. 1). MCMV IE1 is composed o f exons 1-4, while MCMV IE3 is composed of exons
1-3, and 5 (Keil et al., 1987a; Keil et al., 1987b; Messerle et al., 1992). The MCMV ie2
gene (m l 28) is transcribed from a separate promoter in the opposite direction o f the
MCMV iel/ie3 and is composed o f three exons (Keil et al., 1987a; Messerle et al., 1991;
Cardin et al., 1995). However, all three o f these ie genes share the same strong enhancer
(Fig. 1).
The expression o f the MCMV immediate early genes is also driven by a strong
and complex enhancer (Dorsh-Hasler et al., 1985). This enhancer region contains three
long repeats o f 181, 180, and 130 base pairs, and included within these repeats are five 51
base pair repeats containing NF-kB binding sites (Sandford and Bums, 1996). These NFkB binding sites mediate transactivation of the MCMV enhancer by the immediate early
protein IE I (Cherrington and Mocarski, 1989). There are also binding sites for API and
CRE, but no binding sites for NF-1, SP1, or YY1 (Sandford and Bums, 1996). Since AJP1 and NFkB binding sites are present, expression from the enhancer is driven by serum
and growth factors. This stimulation o f the MCMV IE enhancer occurs through a
pathway in which p21 ras is involved (Angeretti et al., 1994). Therefore the enhancer is
active under conditions in which the cell is metabolically active.
In order to determine the importance o f the MCMV major immediate early
enhancer, MCMV mutant viruses have been made in which the MCMV immediate early
enhancer has been deleted. For these MCMV mutants, viral growth is impaired in mouse
fibroblast cells (NIH 3T3 cells). Since viral growth is not inhibited completely, the
enhancer is not essential for viral replication but is required for optimal levels of viral
infection to occur in permissive cells. When the HCMV enhancer is used to substitute for

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

23

the MCMV enhancer (hybrid MCMV strains), the HCMV enhancer is able to restore
growth in fibroblasts to kinetics similar to wild type MCMV (Angulo et al., 1998;
Grzimek et al., 1999). When mice are infected with this virus, liver cells are infected to
similar levels as wildtype virus. However the mutant virus is attenuated in the spleen,
lung, and adrenal gland (Grzimek et al., 1999). This suggests that the MCMV enhancer
is active in a tissue specific manner.
The MCMV IE1 gene product is an 89kDa nuclear phosphoprotein analogous to
the HCMV IE I gene product. The MCMV IE I gene product transactivates the iel/ie3
promoter and several other promoters such as the SV40 promoter, the early HSV-1 gD
promoter, and the NF-kB p!05/p50 promoter (Koszinowski et al., 1986; Gribaudo et al.,
1996). The MCMV IE3 gene product (88kDa) is analogous to HCMV IE2 and represses
the MCMV iel/ie3 promoter. In transient assays using a construct containing the MCMV
MIEP cloned upstream o f the chloramphenicol acetyl transferase (CAT) gene, a low level
o f CAT activity was found with IE1 alone, and this activity was reduced by 5 fold with
IE1 and IE3 (Fig. 3) (Messerle et al., 1992, Cardin et al., 1995).
In addition to having sequence similarity to the carboxyl terminus o f the HCMV
IE2 protein, both MCMV IE3 and HCMV IE2 exhibit functional similarity in activating
the expression o f early genes. The MCMV IE3 protein is a strong transcriptional
transactivator of the murine CMV early promoter el (M l 12-MI 13). In transient assays
using the e l promoter cloned upstream of CAT, IE3 was able to increase CAT activity by
150 fold. When the e l promoter-CAT construct was cotransfected with IE1 and IE3, a
200 fold increase in CAT activity was observed. Therefore, together MCMV IE1 and
IE3 act synergistically in activating the el promoter (Fig. 3) (Messerle et al., 1992).
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Finally, the MCMV LE2 gene product has no obvious counterpart in HCMV, but
it too transactivates the MCMV ie 1/3, the ie2 promoter and the HSV-1 ICP8 promoter
(Cardin et al., 1995). In transient studies o f the MIEP using the Escherichia coli lacZ
gene as a reporter, IE2 was able to activate this promoter 12 fold above basal levels in a
dose dependent manner (Cardin et al., 1995). IE2 was able to autoregulate the expression
o f an IE2 promoter-lacZ construct by 3 fold above basal levels (Cardin et al., 1995).

MIEP

MIEP

▲

IE3

IE3

TEl

++++++

el

FIG. 3. Model of MCMV IE protein function. Influence o f IE 1 and IE3
on the MCMV MIEP and the early e l promoter is depicted. Arrows from the
proteins indicate the interaction o f the proteins and their subsequent influence
on the promoters. The relative levels o f activation (+) and repression (-) of
the promoters by IE proteins are indicated. The lack o f an influence on promoter
activation is indicated by 0 (Messerle et al., 1992).
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Like IE1 o f HCMV, MCMV EE1 is not necessary for growth in cell culture.
When a low MOI was used to infect mouse NIH3T3 fibroblast cells with a MCMV iel
mutant virus, the IE1 mutant grew significantly slower than wild-type virus. However
when the MOI was increased, replication was restored to levels similar to wild type
(Messerle et al., 1997). This can be explained by the phenomenon referred to as
“multiple hits” . When the MOI is high, other factors are able to compensate for the lack
o f IE1 in activating the MIEP. Compensating factors could include transactivating
proteins within the tegument (Mocarski et al., 1996). Although MCMV IE1 is
dispensible for growth in culture, a MCMV mutant deleted o f the MIEP and part o f exon
1 o f iel/ie3 is replication incompetent in cultured ceils (Angulo et al., 1998).
IE2 also is dispensible for growth in NIH3T3 cells. An IE2 deletion mutant
displayed similar growth kinetics as wildtype virus in vitro (Cardin et al., 1995; Manning
and Mocarski, 1998). In vivo, the IE2 mutant virus grows to similar levels as wild type
virus in the spleen, liver, kidney and adrenal glands. In the absence o f IE2, the
establishment o f and reactivation from latency also occurs to levels similar to wildtype
virus (Cardin et al., 1995).

MCMV Non-essential Genes
MCMV genes are classified as either non-essential or essential. The essential
genes are those required for viral attachment/penetration, viral DNA replication in
fibroblast cells, or viral packaging. Non-essential genes are not required for viral DNA
replication in fibroblasts, but likely influence tissue tropism and/or viral pathogenesis.
Several MCMV non-essential genes have been studied to date. The sgg-1 gene (M l33)
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and the G protein-coupled receptor homolog gene (M33) are involved in MCMV growth
in the salivary gland (Lagenaur et al., 1994; Davis-Poynter et al., 1997). The chemokine
homolog m l3 1 is also involved in infection o f the salivary gland by eliciting
proinflammatory signals which may be important for dissemination to or replication of
MCMV in this organ (Fleming et al., 1999).
Like HCMV, several MCMV non-essential genes interfere with the expression o f
MHC class 1 molecules on the surface o f an infected cell. The m l 52 gene blocks antigen
presentation by preventing the export o f MHC class 1 molecules from the endoplasmic
reticulum through the Golgi (Zeigler et al., 1997). The m06 gene allows the MHC class I
molecules to be transported from the endoplasmic reticulum through the Golgi, however
the MHC class 1 molecule is not expressed on the surface o f the cell but is redirected to
the lysosome and rapidly degraded. The mouse gp34 protein (m04), which is also
nonessential, counteracts the MHC class 1 inhibition by m l52 and m06, and associates
with the MHC class 1 molecules as they are transported to the cell surface. This may
allow the infected cell to escape recognition by natural killer cells by increasing MHC
class 1 levels at the cell surface (Kleijnen et al., 1997). Another MCMV non-essential
gene encodes the MCMV IgG Fc receptor (M138).

US22 Gene Family
One gene family likely to influence viral pathogenesis is the US22 gene family.
Members of the US22 gene family have been found in HCMV (Weston and Barrell,
1986), MCMV (Rawlinson et al., 1996), HHV-6 (Nicholas and Martin, 1994), and HHV7 (Nicholas, 1996). These are all betaherpesviruses that infect myeloid and lymphoid
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cells. The functions o f many members o f the US22 gene family are unknown. However
certain members o f the family, HCMV TRS 1/IRS land UL36, MCMV ie2, and some
ORFs within the region o f homology in HHV-6, encode transcriptional transactivators
(Cardin et al., 1989; Stasiak and Mocarski, 1992; Nicholas and Martin, 1994; Iskenderian
et al., 1996).

Conserved motifs contained within the US22 gene family. US22 family members
contain up to four conserved consensus sequences that are referred to as motifs
(Kouzarides et al., 1988; Nicholas and Martin, 1994). The US22 motifs I and II are
composed of conserved sequences containing hydrophobic residues. M otif I contains the
consensus OXOXXPXXW and m otif II contains the consensus OOCCXXLXXOG,
where O is any hydrophobic residue and X is any residue. The remaining two motifs are
less well defined but have stretches of nonpolar residues (Kouzarides et al., 1988)

IRS 1/TRS 1 o f HCMV. IRS1/TRS1 are HCMV US22 family members.
IRS1/TRS1 are partially contained within the repeat elements o f the short component of
the HCMV genome. IRS 1 extends from an internal repeat element into the short unique
domain while TRS 1 extends from a terminal repeat element into the short unique domain.
Therefore, synthesis o f their mRNAs is controlled by repeated promoters and the two
proteins share residues at their amino termini but differ in their carboxyl-terminal
sequences. IRS 1/TRS1 have duplicating function. Therefore, only one o f the two open
reading frames is required for transient complementation o f ori-Lyt dependent viral DNA
synthesis (Jones and Muzithras, 1992). Both mRNA and protein products o f TRS l/IRS 1

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

28

(pTRS 1/pIRS 1) can be detected in all phases o f the viral replication cycle. pIRS 1 and
pTRS 1 are present in both the nucleus and the cytoplasm during the immediate early and
early phases o f the viral growth cycle, but are found predominately in the cytoplasm
during late phases of viral growth (Romanowski and Shenk, 1997).
As stated earlier, TRS 1/IRS 1 are required for HCMV ori-Lyt DNA replication.
TRS 1/IRS 1 cooperate with other immediate early regulatory proteins to promote
expression o f the six replication fork proteins (Pari and Anders, 1993; Pari et al., 1993;
Iskenderian, 1996; Kerry et al., 1996). IRSl/TRSl exhibit little activity as transcriptional
transactivators on its own, but with IE1 and IE2 proteins expression can be enhanced
from a variety o f promoters (Romanowski and Shenk, 1997). For example, both IRS 1
and TRS 1 genes upregulate the activity o f the polymerase accessory protein gene
promoter (UL44) in the presence o f IE 1 and IE2 proteins, but do not transactivate it when
transfected alone (Stasiak and Mokarski, 1992).
An additional immediate early gene product is encoded within the IRS 1 gene.
This gene product called pIRS l 263 is encoded within the 3' end o f the IRS1 gene and is in
the same reading frame as the large pIRSl protein. Expression o f the IRS l 263 gene is
controlled by a promoter that resides within the IRS 1 open reading frame in the unique
short region o f the viral genome. pIRS l 263 accumulates to its highest level during the
early phase o f HCMV infection. This protein resides in the nucleus and antagonizes the
transcriptional activating capability o f pTRS 1 and pIRS 1. pIRS l 263 may therefore serve
as part o f a regulatory loop, preventing overexpression o f some early or late gene
products, optimizing or perhaps slowing the process of viral replication (Romanowski
and Shenk, 1997). Whatever its role, the effect o f pIRS I263 on virus growth in cultured
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fibroblast cells is at best subtle because no clear phenotype was evident for a mutant
lacking the IRS1 coding region (Jones and Muzithras, 1992).
pIRS 1 and pTRS 1 are also present in the HCMV virion. These proteins were not
degraded when intact virions were treated with trypsin, suggesting that the proteins are
localized inside the viral tegument (Romanowski et al., 1997). In contrast the pIRSl263
was not detected in the virions (Romanowski and Shenk, 1997). Virion pIRSl and
pTRS 1 can also activate expression o f viral immediate early promoters in cooperation
with pUL69 but not pUL82 (Romanowski et al., 1997). Both pUL69 and pUL82 are
transcriptional regulatory proteins that are components o f the HCMV tegument (Liu and
Stinski, 1992; Winkler et al., 1994; Winkler and Stamminger, 1996). Therefore
pIRSl/TR Sl may assist in the activation of HCMV promoters as the DNA first reaches
the nucleus (Romanowski et al., 1997).

Table 1. Homology between MCMV and HCMV US22 family genes.
M CM V
M23a
m23.1
M24
m 25.1
m25.2
M3 6
M36 Ex2
M36 Ext
M43
m !28 Ex3
MI39
M140
M141
m !42
m!43

HCMV
UL23b
UL24
UL23
UL22
LTL36
UL36 Ex2
UL36 Ext
UL43(P)C
US22
US22
US23
US24
US26
US23

Potential Function

transactivator
transactivator
transactivator
transactivator
cell tropism
cell tropism
cell tropism
transactivator
transactivator

a M and m denote MCM V genes with and without homology to H CM V genes, respectively.
b UL and US indicate HCMV genes within unique long and unique short regions o f the genome,
respectively.
c H om olog to HCMV according to position in the genome. (Rawlinson, 1996).
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MCMV US22 family members. The HCMV US22 family members are contained
within the US or the UL region o f the genome. In MCMV, several ORFs have homology
to the HCM V US22 family members (Table I). The MCMV US22 family members are
arranged in a similar fashion as those found in HCMV, with two clusters o f tandemly
repeated homologs at either end o f the genome (Fig. 4) (Rawlinson et al., 1996). The
M CM V US22 family members located at the left side o f the genome are more similar to
the HCMV UL family members, and include genes M23, m23.1, M24, m25 and M36
(Fig. 4) (Rawlinson et. al., 1996). The MCMV US22 family members at the right side of
the genome are more US-like and include genes m l28 and M139-ml43 (Fig. 4)
(Kouzarides et al., 1988; Nicholas and Martin, 1994; Nicholas et al., 1996). Products of
the US22 genes M139, M140 and M141 are nonessential for viral replication and are
involved in MCMV cell tropism and pathogenesis (Cavanaugh et al., 1996; Hanson et al.,
1999; M enard, 2000). A mutant virus deleted o f M139-M141 replicates in NIH 3T3
fibroblasts like wild type virus, but replicates three logsio lower in macrophages in vitro.
This virus also replicates poorly in mouse spleen tissue that contains macrophages that
are permissive for wildtype MCMV. However, when these splenic macrophages are
depleted, replication is restored to wild type levels (Hanson et al., 1999). This suggests
that M139, M140 or M141 individually or in combination, is involved in macrophage
tropism. Single mutants deleted of M140 or M141 grow 2-3 logsio lower and 2 logsio
lower respectively, in macrophages compared to wild type virus (Hanson et al., in press).
In fibroblasts M l40 and M141 single deletion mutants grow similar to wild type vims. In
vivo, the M l40 and M141 single deletion mutants are also attenuated for replication in
target organs rich in macrophages (Hanson et al., in press). These data suggest that M140
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and M141 genes are both involved in regulating MCMV growth in macrophages. The
possibility o f M l39 involvement in macrophage tropism was eliminated since M l39
mutant virus grows similar to wild type virus in macrophages and macrophage rich
organs (Hanson et al., in press).
The MCMV US22 family member m l28 (ie2) is an immediate early protein that
activates its own promoter as well as the IE1/IE3 promoter (Cardin et al., 1995).

MCMV Hind HI Map
B

N
-m -\

M H

D

-a a ti"

M23, M3 6 M43
m23.1 M36Ex2,
M24, M 36Exl
m25.1,
m25.2

K LJIO P E
*
m l28 M 139-m l43

FxZi - US22 family genes

FIG 4. Map o f MCMV (Smith strain) denoting location o f US22 family genes.
Members o f the MCMV US22 family influence viral pathogenesis. The location
of these genes within the genome is indicated as shaded boxes (Rawlinson, 1996).
The US22 family members are arranged with two clusters o f tandemly repeated
homologs at either end o f the genome. US22 family members located to the right
side o f the genome are more like HCMV US members while the members on the
left side o f the genome are more similar to HCMV UL family members.

IE2 is dispensible for growth in NIH3T3 cells as well as in the mouse (Cardin et al.,
1995; Manning and Mocarski, 1998). M36 has homology to the US22 family member
UL36 o f HCMV. HCMV UL36, also an immediate early gene product, assists in the
transactivation of genes involved in viral DNA replication (Iskenderian, 1996).
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The US22 family members m l42-ml43 are essential for viral replication in
fibroblasts (Cavanaugh, 1996; Menard et al., 2000). While a virus deleted o f M139M141 is able to grow in fibroblast cells to levels similar to wild type virus, a virus deleted
o f M139-ml43 is helper dependent (Cavanaugh et al., 1996). Also, when MCMV is
mutated within m l42 or m l43, infectious virus does not result upon transfection o f
cultured cells with mutant viral DNA (Menard et al., 2000). Collectively, these data
suggest that m l42 and m l43 are essential genes. The genes m l42-m l43 have homology
to the IRS1/TRS1 transactivator genes o f HCMV (Rawlinson, et ai., 1996). Based on
homology, we hypothesize that m l42-m l43 are functional homologs to ERS1/TRS1. We
test this hypothesis in this proposal.

MCMV Immediate Early Genes m l42 and m l43
US22 family members m l42 and ml43 have some homology to IRS1/TRS1 of
HCMV, and are located within the Hind III I fragment o f MCMV (Fig. 4). The ml42
transcript corresponds to a 1.8 kb RNA and the ml43 transcript corresponds to a 3.8 kb
transcript. The transcriptional start site of m l 42 and m l 43 genes have been identified by
nuclease mapping. For the transcript mapping, a 5’ end probe was hybridized to RNA
from NIH 3T3 fibroblast cells that were infected for either 3 hours (early times) or 24
hours (late times). Analysis o f the m l 43 transcript revealed two major protected bands of
identical size at 3 hours post infection and 24 hours post infection. These bands
correspond to the initiation of m l43 expression at nucleotides 202686 or 202694. For
m l42, at early times a protected band was found which corresponds to a start site at
nucleotide 200847. However, an additional minor band was found which corresponds to

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

33

a start site at nucleotide 200848 (Fig. 5). This suggests an additional initiation site for
m l42 expression (Fig. 6). At late times, the same bands w e re present along with another
protected band that may correspond to ml42c. The m !42c s ta rt site was not mapped in
these studies (Fig. 6) (Hanson et al., 1999).
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FIG . 5. Map of the m l42 and ml43 proteins. The location of
conserved US22 family motifs, and other predicted motifs are
shown for A) m i42 and B) m l43. The locatio»n o f the m l42 and
m l43 genes within the MCMV genome are a ls o indicated, with
the TATA Box, 5’ end of the transcript, and com m on restriction
enzyme sites denoted. Numbers refer to nucl&otides within the
MCMV genome.

Analysis for protein motifs show that in addition to th_e US22 motifs, m l42 has an
acidic domain that is common to all herpesvirus transcriptioaal transactivators. The ORJF
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m l43 contains potential bipartite nuclear localization signals, as well as several Nglycosylation sites (Fig. 5).
In summary, genes m l42 and m l43 are members o f the US22 gene family. This
gene family is known for its biological importance, by influencing viral pathogenesis.
Since m l42 and m l43 are required for viral DNA replication in fibroblast cells, the role
they play during a MCMV infection is a vital one. Thus far, the m l42 and m l43
transcripts have been identified, and their transcriptional start sites have been mapped.
The experiments in this dissertation will give us more knowledge about these essential
genes and their function during a MCMV infection.
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FIG . 6. Transcripts originating from the MCMV m l42 and m l43 gene
region. A. Potential m l42 and m l43 open reading frames (ORFs) are
indicated by closed boxes. Overlapping ORFs are indicated above the
closed boxes. The poly A, TATA box, and common restriction sites are
denoted. Numbers refer to nucleotides within the MCMV genome. B. The
position and sizes of the m l42 and m l43 transcripts (Hanson et al., 1999).
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CHAPTER H
SUMMARY OF EXPERIMENTAL PLAN
As previously stated, m l42 and m l43 are members of the US22 gene family of
HCMV. Some members o f this family, HCMV TRS 1/IRS land UL36, MCMV ie2, and
some ORFs within the region of homology in HHV-6, encode transcriptional
transactivators (Stasiak and Mocarski, 1992; Nicholas and Martin, 1994; Cardin et al.,
1995; Iskenderian et al., 1996). The genes m l42-m l43 also have homology to HCMV
IRS 1/TRS1 which are involved in the activation o f viral early genes involved in viral
DNA replication (Iskenderian et al., 1996). Furthermore, these genes are expressed at one
hour post infection which suggests that they may be immediate early genes. Most of the
betaherpesvirus immediate early gene products discovered to date function as
transcriptional transactivators. Therefore it is likely that m l42 and/or m l43 are
functional homologs o f IRS 1/TRS 1 and function as transcriptional transactivators.
The specific objectives of this study were:
1) To determine to which kinetic class the m l42 and m l43 genes belong:
immediate early, early or late. In order to do this, NIH3T3 cells were infected in the
presence o f drug inhibitors that block MCMV replication at immediate early, and early
times. The drug anisomycin blocks de novo protein synthesis, thus allowing the
expression o f only the immediate early genes. The drug phosphonoformate prevents viral
DNA replication, allowing the expression of only the early genes. Late genes are
expressed in the absence o f drug inhibitors.
2) To generate polyclonal antisera against m l42 and ml43 proteins. Since the
m l42 and the m l43 proteins have not been previously described, m !42 and ml43
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specific antiserum was needed. Therefore, m i42 and ml43 were cloned separately, in
frame with a histidine tag. The histidine tagged m l42 and m l43 fusion proteins were
expressed and then purified using a nickel-chelating column. Following purification the
proteins were injected into rabbits for antibody production. Once the m l42 and ml43
specific rabbit anti-serum was obtained, experiments were done to ensure the specificity
o f these antibodies.
3) To characterize the m l42 and m l43 proteins. Since the m l42 and ml43
proteins have not been previously described, the size and expression kinetics o f these
proteins were determined. For the kinetics studies, NIH3T3 cells were infected with
MCMV at an MOI of 2 for 0, 3, 6, 12, or 24 hours. Next lysates from these infected cells
were analyzed by Western blot to determine the molecular weight and time o f expression
o f m l42 and ml43 proteins.
4) To determine the localization of m l 42 and ml 43 proteins within an MCMV
infected cell. Since it was proposed that m l42 and/or ml43 are transcriptional
transactivators, it was o f great interest to determine if they localize to the nucleus. In
order to determine this, immunofluorescence assays were done to localize the m l42 and
m l43 protein products to at least the nucleus or the cytoplasm. These
immunofluorescence studies were performed at 24 hours post infection. Cell
fractionation experiments allow the separation of the nuclear and cytoplasmic fractions of
infected cells. This procedure was also used to determine if m l 42 and m l 43 localize to
the nucleus or cytoplasm at various times post infection.
5) To determine the ability o f m l42 and ml43 to function as transcriptional
transactivators. Gene products m l42 and m l43 could have several possible functions as
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transcriptional transactivators. The m l42 and m l43 gene products could a) transactivate
the MCMV iel/ie3 promoter, b) transactivate the promoters o f MCMV early genes
whose products participate in MCMV DNA replication, c) transactivate other early or
late genes whose products do not function in MCMV DNA replication, or d) serve as a
co-activator with IE1 and/or IE3 to enhance transcription of MCMV genes. We
determined the transactivation function o f m l42 and m l43 by testing their ability,
individually and collectively, to activate selective MCMV promoters. First, it was
determined if m l 42 and/or m l 43 can transactivate the iel/ie3 promoter. We also
determined if m l42 and/or m l43 might serve as a co-activator of the iel/ie3 promoter
along with EE1 and IE3. Our next goal was to determine if m l42 and/or m l43 can
activate the promoter o f the MCMV early gene e l (M l 12-MI 13). The MCMV e l gene
has homology to HCMV UL112-113, which is required for HCMV DNA replication
(Pari and Anders, 1993). We also determined if m l4 2 and/or ml43 might serve as a co
activator o f the el promoter along with EE1 and IE3.
Genes m l42 and m l43 are essential for viral DNA replication in fibroblasts cells.
Therefore, these gene products play a vital role in the biology o f MCMV. These studies
are very important because they characterize these proteins that are necessary for viral
growth, as well as assign a potential function to these proteins. This information will
provide a foundation for studying the role o f these genes in the context o f a viral
infection. In the future, m l42/m l43 mutant viruses will be generated for this purpose.
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CHAPTER IH
MATERIALS AND METHODS
Cell line
NIH 3T3 cells, a contact-inhibited murine fibroblast cell line from American Type
Culture Collection (Rockville, MD), were propagated in Dulbecco’s Modified Eagle’s
Medium (Mediatech, Herndon, VA) supplemented with 10% heat inactivated bovine calf
serum (Hyclone Laboratories, Logan, UT) and 1% L-glutamine (Mediatech, Hemdon,
VA).

Virus
The Smith strain o f murine cytomegalovirus (MCMV) was obtained from the
American Type Culture Collection (Rockville, MD). Stocks of virus were prepared in
and titered on NIH3T3 fibroblasts, as previously described (Campbell et al., 1989).

Plasmid constructions
Plasmid cloning was conducted by standard methods (Maniatis et al., 1987), and
each plasmid was tested by restriction endonuclease digestion to ensure that the correct
DNA sequences were inserted. The restriction endonuclease digestions were done
according to manufacturer’s suggestions. The plasmids to be used for the transfection
studies were prepared and purified using cesium chloride/ethidium bromide
centrifugation (Current Protocols in Molecular Biology, 1998) or the Quantum Prep
Plasmid Maxiprep Kit (Bio-Rad, Hercules, CA).
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Plasmids encoding MCMV immediate early proteins were kindly provided by Dr.
Martin Messerle (Messerle et al., 1992). These include plasmid pp89UC, pIE3, and
pIEl 11 that encode the MCMV immediate early proteins EE1, IE3, and IE1+IE3
respectively. The plasmid pMCMV3CAT, which contains the MCMV iel/ie3
promo ter/enhancer sequence upstream o f the chloramphenicol acetyl transferase (CAT)
gene and the plasmid el CAT, which contains the MCMV 112-113 promoter upstream of
the CAT gene, were provided by Messerle as well.

Generation of m l 42/ m l 43 expression vectors. A construct expressing both ml 42
and m l 43 genes, under the control o f their natural promoters, was generated for use in
transient assays. This construct was made by digesting the Hind III I clone of MCMV
with BsrGl (New England Biolabs, Beverly, MA) and Hind III (Promega, Madison, WI).
Next, the 4.6 kb linearized molecule containing m l42-ml43 was isolated from a 5%
acrylamide gel. The plasmid pSVZeo (Invitrogen, Carlsbad, CA) was linearized with
Acc65I (MBI Fermentas, Amherst, NY), treated with calf intestine alkaline phosphatase
(Boehringer Mannheim, Indianapolis, IN) for an hour, and gel purified. Since DNA
digested with the enzymes BsrGl and Acc65I have compatible ends, the 4.6kb fragment
containing m 142/m 143 was cloned into the Acc65I site of pSVZeo (Invitrogen, Carlsbad,
CA). This constmct was called Zeo-I4.6.
The construct ZeoI-4.6 was not optimal for use in the transient assays, because of
problems with high basal levels o f chloramphenicol acetyl transferase (CAT) activity in
the CAT assays. Therefore, we generated another construct that expresses m l42-m l43
under the control of their native promoters. In order to do this, the construct Zeo-I4.6
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was digested with Hind III and EcoR l, and the 4.6 kb insert was isolated from an
acrylamide gel. The Hind III and EcoRI sites are located in the multiple cloning site of
the pSVZeo vector (Invitrogen, Carlsbad, CA) on opposite sides o f the insert containing
m l42/m l43. The vector pCDNA3.I was also digested with Hind III and EcoRl,
followed by phosphatase treatment for an hour, and gel purification. The 4.6 kb fragment
containing m l42/m l43 was cloned into the Hind III/ EcoRl site o f pCDNA3.1. This
construct was called 142/I43pCDNA.

Generation o f 142pCDNA and 143pCDNA expression vectors. Vectors
expressing either m l42 (142pCDNA) or ml43 (143pCDNA) were also generated for use
in transient assays. The 142pCDNA and 143pCDNA constructs were made by
polymerase chain reaction. The primers used for the generation o f p 142 include MCMV
sequences 200502-200517 for the forward primer (sequences TCTCCACCCGAATTC
CCGCTGCCG) and MCMV sequences 199417-199442 for the reverse primer
(sequences CGAGGCGATATCCCGTCCGTCCGTC). These primers were generated by
Life Technologies (Rockville, MD). The 142/143pCDNA vector was used as the
template DNA for PCR. The PCR product generated with the use o f these primers (1.1
kb) was digested with EcoRl and EcoRV. The expression vector pCDNA3.1 was also
digested with EcoRl and EcoRV, and treated with phosphatase for an hour. The DNA
fragments were run on a 5% polyacrylamide gel and eluted. The 1.1 kb fragment
containing m l42 was then cloned into the pCDNA3.1 vector (Invitrogen, Carlsbad, CA)
under the control of the HCMTV major immediate early promoter/enhancer (MIEPE), and
this construct was called 142pCDNA.
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The 143pCDNA vector was also generated using PCR. The MCMV sequences
202602-202626 were used as the forward primer (sequences TCCGCTCGAATTCGTC
CGCCCGTC) and MCMV sequences 200873-200899 were used as the reverse primer
(sequences GGGCGGGTGATATCAGAGATGACATG). These primer sequences were
also generated by Life Technologies (Rockville, MD). The expression vector
142/143pCDNA was used as the template DNA. The PCR product (1.7 kb) was then
digested with EcoRl and EcoRV. The expression vector pCDNA3.1 (Invitrogen,
Carlsbad, CA) was also digested with EcoRl and EcoRV, and phosphatase treated for an
hour. The DNA fragments were run on a 5% polyacrylamide gel and eluted. The 1.7 kb
fragment containing m l43 was then cloned into the pCDNA3.1 vector (Invitrogen,
Carlsbad, CA) under the control o f the HCMV MIEPE and this construct was called
143pCDNA.

Generation o f ml42pBad/HisA and m !43pBad/HisA. Constructs were generated
that contain the m !42 or m l43 gene cloned in frame to sequences encoding the Xpress
epitope and six histidine tags. These constructs were made using the pBADHisA vector
(Invitrogen, Carlsbad, CA) in order to generate histidine-tagged m l42 or ml43 fusion
proteins that would later serve as immunogens for the production o f m l 42 and ml 43
polyclonal antisera. The polyhistidine tags allow purification of the recombinant fusion
protein on a metal-chelating resin and the Xpress epitope permits detection of the
recombinant fusion protein by the anti-Xpress antibody. This vector also allows the
expression of the inserted gene to be strictly regulated. Expression from the plasmid
pBADHisA (Invitrogen, Carlsbad, CA) occurs only in the presence o f arabinose.
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In order to generate a construct containing the histidine and Xpress tagged m l43
recombinant gene, the plasmid Zeo-I4.6 was digested with Kpnl (New England Biolabs,
Beverly, MA). The plasmid Zeo-I4.6 contains both m l42 and m l43. Next the digest
was run on an acrylamide gel and the 1.8 kb fragment (MCMV sequences 200526202422) containing the m l43 open reading frame was eluted. The vector pBad/His A
was digested with K pnl (New England Biolabs, Beverly, MA) and treated with calf
intestine alkaline phosphatase (Boehringer Mannheim, Indianapolis, IN) for an hour, then
gel purified. The 1.8 kb fragment containing m l43 was ligated into the pBad/His A
vector which was linearized with Kpnl. This construct was called m l 43 pBad/His A. The
vector Zeo-I4.6 was also digested with Kpnl and EcoRl (Promega, Madison, WI) in
order to generate a construct containing the histidine and Xpress tagged m l42
recombinant gene. The 1.6 kb fragment (MCMV sequences 198878-200526) containing
m l42 was eluted from an acrylamide gel. The vector pBad/HisA was digested with
Kpnl and EcoRl, and treated with calf intestine alkaline phosphatase (Boehringer
Mannheim, Indianapolis, IN) for an hour, then gel purified. The 1.6 kb fragment
(containing m l42) was inserted into the pBad/HisA vector which was digested with Kpnl
and EcoRl. This vector was called ml42pBad/HisA.

Procedures
Expression from ml42pBad/HisA and ml43pBad/HisA.

The Kpnl-EcoRl

fragment containing m l42 (MCMV sequences 198878-200526) or the Kpnl-Kpnl
fragment containing m l43 (MCMV sequences 200526-202422) was cloned in frame to
sequences encoding six polyhistidine tags and the Xpress epitope using the pBAD/HisA
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vector (see above). These plasmids were used to transform TOP 10 E. coli. In the
presence o f arabinose, expression from pBAD/HisA is turned on while in the absence o f
arabinose very low levels o f transcription occur. Since each recombinant gene has
different characteristics that may affect optimum expression, it was necessary to vary the
arabinose concentration to determine the best condition for optimal expression o f m l42
and m l43. The arabinose concentration was varied over a 10,000 fold range (0.00002%0 .2 %).
For both the pm l42 and the pml43 TOP 10 transformants, the expression studies
were performed as follows. Briefly, 2 ml o f LB containing 50 pg/ml o f ampicillin was
inoculated with a single recombinant TOP 10 colony and incubated overnight at 37°C
with vigorous shaking. The next day, 10 ml o f LB containing 50 pg/ml ampicillin was
added to five tubes. Each tube was inoculated with 0.1 ml o f overnight culture and
allowed to grow at 37° C to a 0.5 OD 6oo- Next, 20 % arabinose was added to each tube
to give the following final concentrations o f arabinose: 0.00002%, 0.0002%, 0.002%,
0.02% and 0.2%. These cultures were grown at 37° C with shaking for 4 hours. From
each culture a I ml aliquot o f cells was taken. Next the cells were pelleted and the
supernatant was removed by aspiration. The cell pellet was then frozen at -2 0 ° C. Each
sample was resuspended in 100 pi o f I x SDS-PAGE sample buffer and boiled for 5
minutes. Each sample was then analyzed by Western blot using the anti-Xpress antibody
(Invitrogen, Carlsbad, CA).
It was found that the optimal concentration for the expression o f m l42 was 0.2%
arabinose and the optimal concentration for the expression m l43 was 0.02% arabinose.
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Using the given concentrations o f arabinose, 250 ml cultures o f the recombinant protein
were prepared, and used for recombinant protein purification.
Initially we tried to purify the m I42 and ml43 protein products using only the
Xpress™ purification system (Invitrogen, Carlsbad, CA). The Xpress purification system
involves the lysis of Top 10 E. coli expressing m l42 or ml43 protein in guanidinium
lysis buffer, removal of insoluble bacterial debris, purification o f the recombinant protein
using a metal chelating column, and elution of the histidine tagged m l 42 or m l 43 protein
from the column. These attempts were unsuccessful because the m l42 and ml43
proteins were insoluble proteins found in inclusion bodies, which were discarded with the
bacterial debris. The m l42 and m l43 proteins were proven to be insoluble proteins when
the pellet containing the bacterial debris was solubilized using the Inclusion Body
Solubilization Reagent (Pierce, Rockford, IL) and analyzed by W estern blot using the
anti-Xpress antibody. Both m l42 and m l43 proteins were detected in the inclusion
bodies using this method.
Therefore in order to correct for this problem, we used several different
commercial reagents and followed the instructions detailed by the manufacturer. Top 10
E. coli expressing m l42 or m l43 were pelleted, and lysed using the B-PER™ Bacterial
Protein Extraction Reagent (Pierce, Rockford, IL). The bacterial lysate was then
centrifuged and the precipitated protein was solubilized using the Inclusion Body
Solubilization Reagent (Pierce, Rockford, IL). The proteins were then purified using the
Xpress™ purification system (Invitrogen, Carlsbad, CA) under denaturing conditions.
Using this system, the histidine tagged m l42 or ml43 fusion proteins were allowed to
bind to a metal chelating column, and then eluted from the column. The eluted protein
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was then checked to make sure that m l42 or m l43 proteins were present by Western blot
using the anti-Xpress antibody. As expected, a band o f 42 kD was detected for the
histidine tagged m l42 recombinant protein and a band o f 56 kD was detected for the
histidine tagged m l43 recombinant protein. The purified proteins were then sent to
Cocalico Biologicals, Inc. (Reamstown, PA) for rabbit injection. Two rabbits were
immunized with the same preparation o f recombinant protein.

Western Blot Analysis. Western blots were conducted as previously described
(Pari and St. Jeor, 1990). Briefly, NIH3T3 cells were harvested in Western lysis buffer
(50 mM Tris, 1% SDS, pH 7.5). The samples were subjected to SDS-PAGE on 12.5%
gels, and transferred to nitrocellulose membranes (Boehringer Mannheim, Indianapolis,
IN). The blots were treated with protein blocking solution containing 5% milk diluted in
0.1% Tween 20/TBS (lOmM Tris, 150 mM NaCl) overnight at 4°C, and then incubated
with a primary antibody for one hour at room temperature at a 1:100 dilution in milk (5%
milk diluted in 0.1% Tween 20/TBS). The blots were washed three times in 0.1% Tween
20/TBS at room temperature, and then incubated with a horseradish peroxidase (HRP)conjugated secondary antibody (Sigma, St. Louis, MO) (diluted 1:10,000) in 5% milk for
one hour at room temperature. Following three more washes in 0.1% Tween 20/TBS,
antibody binding was detected by chemiluminescence using the ECL Western Blotting
Detection Kit (Amersham Pharmacia Biotech, Arlington Heights, IL) on Fuji RX film.

DNA Transfection. Transient transfection experiments were done using the
Transfast Reagent (Promega, Madison, WI). This reagent utilizes cationic liposomes to
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deliver nucleic acid to eukaryotic cells. Briefly, low passage NIH 3T3 cells were plated
the day before transfection in 60 mm dishes at 3xl05 cells/dish. The Transfast Reagent
(Promega, Madison, WI) was also suspended in nuclease free water the day prior to
transfection. To suspend the Transfast, the vial of Transfast Reagent and nuclease free
water were warmed to room temperature. The nuclease free water was added to the vial
to create a volume o f ImM o f cationic lipid component (400 pi per 0.4 mg vial). After
adding the nuclease free water, the sample was vortexed vigorously for 10 seconds to
suspend the lipid film. The Transfast Reagent was then frozen at —20° C overnight. At
the time of transfection, the vial o f Transfast Reagent was warmed to room temperature.
Serum free media and complete media (containing serum) were warmed to 37° C. The
Transfast Reagent/DNA mixture was then prepared. A total o f 5 pg o f plasmid DNA was
added to 2 ml o f serum free media and the mixture was vortexed briefly. Next a 1:1
charge ratio of Transfast Reagent to DNA was added to the DNA mixture (15 pi
Transfast per 5pg o f DNA ) and vortexed immediately. The Transfast/DNA mixture was
then allowed to incubate at room temperature for 10-15 minutes. After the incubation
period, the DNA mixture was vortexed briefly. Next the medium was removed from the
cells and the DNA mixture was added. The cells were then allowed to incubate at 37° C
for one hour. At the end o f the incubation period, the cells were gently overlayed with 4
mis o f complete media and returned to the incubator for 48 hours. The overall
transfection efficiency using this method was about 10%.

Transfection /Superinfection. Since the NIH3T3 cells transfected using the
Transfast reagent did not demonstrate cytopathic effect (CPE) subsequent to MCMV
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infection, transfection/superinfection experiments were done using the Cytofectene
reagent (Bio-Rad, Hercules, CA). Approximately 3 x l0 5NIH 3T3 fibroblast cells were
seeded into 25 mm tissue culture flasks the day before transfection. Next the plasmid
DNA/Cytofectene mix was prepared. First 9 pi o f Cytofectene mix was added to 100 pi
o f Dulbecco’s Modified Eagle’s Medium (DMEM) per sample. This mix (mix I) was
incubated at room temperature for 10 minutes. Next 6 pg o f plasmid DNA was mixed
with 100 pi o f DMEM (mix 2). Next the Cytofectene solution (mix I) was added to the
plasmid DNA solution (mix 2) and incubated at room temperature for ten minutes. This
Cytofectene/DNA mix was then incubated at 4° C overnight.
The following day, the Cytofectene/DNA mix was allowed to reach room
temperature. Next 2 ml o f complete 3T3 media were added to each Cytofectene/DNA
sample and mixed. The cells were washed with sterile PBS and the Cytofectene/DNA
mix was added to the cells. The cells were incubated for at least 5 hours at 37° C, the
Cytofectene/DNA mix removed, the cells washed with PBS, and NIH 3T3 complete
media added. After 24 hours post transfection, the cells were split 1:2 into a 60 mm dish.
The following day the cells were infected with the appropriate multiplicity o f infection
for one hour. Following the infection, complete medium was added to the cells.

Chloramphenicol Acetyl Transferase Assays. Approximately 3x10s NIH 3T3
fibroblast cells were seeded into 60 mm tissue culture dishes the day before transfection.
A total o f 5 pg o f plasmid (including the transcriptional transactivators and MCMV
reporter-CAT constructs) were transfected into cells using the Transfast Reagent
(Promega, Madison, WI) at the indicated concentration. The empty vector pCDNA3.1
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was used to maintain a constant amount o f plasmid DNA per transfection. At 48 hours
post-transfection, the cells were harvested. Briefly, the transfected cells were washed
twice with 3 mis o f Tris Buffered Saline (TBS)(30mM Tris, 150mM NaCl, pH 7.4), then
scraped off the plates into 0.4 ml o f TBS. Next the cells were pelleted and resuspended
in 100 pi o f 0.25 M Tris-HCL pH 7.8. Following three rounds o f freezing in an ethanol
dry ice bath and thawing at 37° C, the cell lysates were centrifuged and the supernatants
were transferred to new tubes. The extracts were then heated to 68° C for 10 minutes and
the amount o f protein per extract was determined using the BCA Protein Assay Kit
(Pierce, Rockford, II). Equal amounts o f protein (15 pg o f protein per sample) were used
in each sample to be analyzed for CAT activity. The standard CAT assay contains 20 pi
o f extract (containing 15 pg o f protein in 0.25 M Tris pH 7.8), 70 pi 0.25 M Tris pH 7.8,
20 pi o f 4 mM acetyl coenzyme A, 34 pi o f H 2 O, and O.lpCi of [14C] chloramphenicol
(Amersham Pharmacia Biotech, Piscataway, NJ) in a reaction volume o f 125 pi.
Reactions were carried out for 30 minutes at 37° C, extracted with ethyl acetate, and the
extracted products were dried in a Speed Vacuum Concentrator. Reaction products were
resuspended in 20 pi o f ethyl acetate, spotted onto silica gel thin layer chromatography
plates and the products were separated by ascending chromatography using 95:5
chloroformrmethanol (190ml chloroform/10ml methanol). After autoradiography, each
form o f chloramphenicol was quantitated using a Phosphorimager (Molecular Dynamics,
Sunnyvale, CA). The reactions were linear for at least 30 minutes for up to 50%
acetylation. When above 50% acetylation occurred during the 30 minute incubation, the
assay was repeated using less protein. Experiments were repeated a minimum o f three
times and the average o f three experiments were shown.
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Northern Blot Experiments. Approximately

1 x 1 0 6 NLH

3T3 cells were seeded

into 100 mm tissue culture plates the day before infection. The fibroblasts were either
mock infected or infected with wild type (WT) MCMV at a multiplicity o f 2 PFU per
cell. Following virus adsorption at 37° C for one hour, the inoculum was removed, and
10 ml o f culture media were added. For immediate early RNA isolation, 100pM
anisomycin was added to the cells one hour prior to and during infection. For early RNA
isolation, phosphonoformate was added to the culture media at a concentration of 300 pg
per ml at the time o f infection. For late RNA isolation, RNA was harvested from cultures
at 24 hours after infection. Total RNA was harvested using the Qiagen Rneasy kit for
total RNA isolation (Qiagen, Chatsworth, CA). Northern blots were conducted as
described by Maniatis and coworkers (1987). RNA samples were quantitated at 260 nm,
and 5 ug o f each sample was loaded into the well o f a 1.5% agarose/6.6% formaldehyde
gel and electrophoresed overnight at 20 volts. The following day, the gels were rinsed
three times in sterile distilled water (10 minutes per wash), and transferred to a
positively-charged nylon membrane overnight in 20XSSC (3M NaCl, 300 mM sodium
citrate, pH 7.0). In some cases the gels were treated to enhance transfer o f large RNA
species by partial alkaline hydrolysis. This includes soaking for 30 min in 0.05 M
NaOH/1.5 M NaCl followed by neutralization in 0.5 M Tris/1.5 M NaCl (pH 7.5) prior to
blotting. After transfer, the membranes were UV cross-linked (150J), and baked at 80°
for 30 minutes. The Boehringer Mannheim Genius System (Boehringer Mannheim,
Indianapolis, IN) was used to detect hybridized probes o f MCMV DNA labeled with
digoxygenin-11-dUTP/dATP. Bands were visualized using the chemiluminescent
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substrate disodium3-(4-methoxyspiro{l,2-dioxetane-3,2’-(5’-chloro)tricyclo [3.3.1.13’7]
decan}-4-yl) phenyl phosphate which is referred to as CSPD.

Cell Fractionation Experiments. The NE-PER Nuclear and Cytoplasmic
Extraction Reagent (Pierce, Rockford, IL) was used to determine the localization of
pm l42 and pm l43 within an MCMV infected cell. Approximately 1x 106NIH 3T3 cells
were seeded into 100 mm tissue culture plates the day before infection. The fibroblasts
were either mock infected or infected with wild type (WT) MCMV at a multiplicity o f 5
PFU per cell. Following virus adsorption at 37° C for one hour, the inoculum was
removed, and 10 ml o f culture media were added. At the indicated time post infection,
the cells were washed with sterile PBS, scraped from the plate, transferred to a 1.5 ml
microcentrifuge tube, and pelleted. Next 100 pi of cytoplasmic extraction reagent 1
(CER1) were added to the cell pellet and vortexed vigorously for 15 seconds. The tube
was then placed on ice for 10 minutes. Next 11 pi o f C ER II were added to the tube,
vortexed, and placed on ice for 1 minute. After vortexing again, the tube was centrifuged
for 5 minutes at maximum speed (16,000XG). The supernatant, which contains the
cytoplasmic extract, was then transferred to another tube then placed on ice. The
insoluble pellet was then resuspended in 100 pi o f nuclear extraction reagent (NER) and
vortexed for 15 seconds. The sample was then placed on ice and vortexed for 15 seconds
every 10 minutes for a total of 40 minutes. The nuclear fraction was then centrifuged at
16,000XG, and the supernatant, which contains the nuclear fraction, was removed. The
samples were stored at —80° C until use.
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The nuclear and cytoplasmic fractions were analyzed by Western blot analysis
using m l42 and m l43 polyclonal antisera as described above. As a control to ensure that
minimal nuclear contamination o f the cytoplasmic fraction occurred, the antibody against
phosphotyrosine phosphatase-PEST (PTP-PEST) was used in the Western blot detection.
The PTP-PEST protein is a mouse cytoplasmic protein. The PTP-PEST antibody was
kindly provided by Dr. M. Tremblay (Department o f Biochemisty, McGill University,
Montreal, Canada).

Immunofluorescence. Immunofluorescence was also used to determine the
localization o f the m l42 and m l43 proteins. The day prior to infection approximately
1x 105NIH 3T3 cells were seeded per chamber on chambered slides. The next day these
cells were either mock infected or infected with MCMV at an MOI of 5 for an hour at 37°
C, the viral inoculum removed, complete media added, and the cells incubated for 24
hours at 37° C. After the 24 hour incubation, the growth medium was removed and the
cells were washed two times with PBS containing Ca2_r and Mg2+. Cells were fixed in 2%
paraformaldehyde (diluted in PBS, pH 7.4) for 10 minutes at room temperature.
Following fixation, the cells were rinsed twice with Ca2+/M g 2-r free PBS, and
permeabilized with PBS containing 0.5% triton X 100 for 8 minutes at room temperature.
The slides were stored at 4° C overnight. For the staining procedure, the cells were first
rehydrated in 0.1% bovine serum albumin (BSA)/PBS. Next the primary antibody (anti142 or anti-143) was added to the slides at several dilutions (1:100, 1:1000) in 0.1%
BSA/PBS, and the slides incubated for one hour at 37° C. Control chambers were
incubated with preimmune serum in 0.1% BSA/PBS at the same dilutions. As a positive
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control, the e l antibody was used (obtained from Dr. Gina Ciocco-Schmitt, Eastern
Virginia Medical School, Norfolk, VA). Following primary antibody, the cells were
washed three times with 0.1% BSA/PBS, and incubated with goat anti-rabbit antiserum
conjugated with FITC (Sigma, St. Louis, MO) at a 1:100 dilution for 1 hour at 37° C.
The slides were washed twice with 0.1% BSA/PBS, once with distilled water, and then
air dried. The coverslips were mounted on the slides with mounting fluid and viewed
under a confocal microscope (Olympus Fluoview 100). Different Z-series o f the images
were taken at 1-pM intervals and projected onto a single plane.
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CHAPTER IV
RESULTS
Kinetics of m l42 and ml43 Transcript Expression
Since m !42 and m l43 are essential genes, we wanted to determine at what time
during viral infection m l4 2 and m l43 are expressed. In order to do this, a time course
experiment was done. In this experiment RNA was harvested from NIH3T3 infected
cells at 0, 1, 3, 6, and 16 hours after infection. This RNA was then analyzed by Northern
blot using a DNA probe containing the Sst-Sst fragment o f MCMV from this region (Fig.
6) (Hanson et al., 1999).
The m l42 and m l43 genes were expressed by one hour post infection, and reach
maximal levels by three hours post infection. The m l42 transcript corresponds to a 1.8
kb RNA and the m l43 transcript corresponds to a 3.8 kb RNA (Fig. 6B. and 7). Levels
o f these transcripts remained abundant at six and sixteen hours post infection (Hanson et
al., 1999). It appears that the 1.8 kb m l42 transcript may shift to a 1.6 kb RNA species
as time progresses, since at late times a 1.6 kb ml42 band predominates over the 1.8 kb
band (Fig. 7 ). This could be explained by a variation in the size o f the polyadenylation
signal. Alternatively, the shorter 1.6 kb transcript may be generated by splicing, since
splice donor and acceptor sites are dispersed throughout this gene. However, nuclease
mapping would have to be done to confirm this. According to the expected size o f the
ml42b transcript, the 1.6 kb band could also be transcribed from m l42b (Fig. 6) (Hanson
et al., 1999).
The Sstl-S stl probe contains 404 nucleotides o f the M141 gene. Therefore, the
7.0 kb M l41 transcript was detected as well. The 5.1 kb transcript was expressed from
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Hours Post Infection
M l
3 6 16

ml43

m l 42

FIG 7. Time course o f expression o f m l42 and m l43 transcripts. NIH 3T3
fibroblast cells were either mock infected (M) or infected with 5 PFU/cell o f wild
type MCMV for the indicated times (hours post infection). RNA was isolated as
described in the Materials and Methods. The gel was treated by partial alkaline
hydrolysis to enhance transfer of larger RNA species and probed with a labeled
probe spanning the m l42 and ml43 gene region. Numbers to the left denote sizes
(Kb) (Hanson et al., 1999).

m l44. Although the Sstl-Sstl probe is outside o f the m l44 gene region, the m l44
transcript was detected because m l42, ml43 and m I44 have 3’ coterminal transcripts
(Hanson et al., 1996).

m l42 and ml43 Are Immediate Early Genes
Since m l42 and m l43 were expressed at one-hour post infection, we speculated
that these might be novel immediate early genes not previously identified. By definition,
immediate early genes are those expressed in the absence o f de novo protein synthesis.
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The drug anisomycin prevents de novo protein synthesis thus allowing the expression o f
only the immediate early genes during an MCMV infection.
We therefore determined if m l 42 and ml 43 are true immediate early genes. In
order to do this, NIH 3T3 fibroblast cells were infected in the presence o f anisomycin.
Under these conditions, both m l42 and m l43 were detected when a probe containing the
Sst I-Sst I fragment o f MCMV corresponding to this region was used (Fig. 6A, 8).
Therefore, m l42 and m l43 are true immediate early genes (Fig. 6B, Fig. 8). Under these
conditions MCMV IE1 and IE3 are abundantly expressed, while early genes like m l44
are absent (data not shown). This proves that the anisomycin treatment was effective in
that only the immediate early genes were expressed.
These genes were also expressed in the presence of the viral DNA replication
inhibitor phosphonoformate, suggesting that these genes are also expressed at early times.
At early times, it was also evident that a 1.6 kb and a 2.2 kb transcript were expressed
(Fig. 8) (Hanson et al., 1999). Both m l42 and ml43 were expressed at late times o f
MCMV infection as well (24 hours post infection) (Fig. 8). Therefore m l42 and m l43
are true immediate early genes, and are also expressed at early and late times o f MCMV
infection.
We were surprised to find that the expression of m l42 and m l43 is very different
from the expression o f the other MCMV immediate early genes. For example, the
immediate early genes iel and ie3 are expressed at abundant levels in the presence o f the
protein synthesis inhibitor cycloheximide (Messerle et al., 1991). However MCMV IE
transcripts iel and ie3 are absent when NIH 3T3 cells are infected in the presence o f the
DNA replication inhibitor phosphonoacetic acid, and therefore do not accumulate at early
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FIG. 8. m l42 and m l43 are newly identified genes expressed at
immediate early times. NIH 3T3 fibroblasts were infected with
2 PFU MCMV/cell and RNA was isolated. Immediate early (IE)
RNA was produced in the presence o f 100 pM anisomycin, early (E)
RNA was produced in the presence o f 300 ug/ml o f phosphonoformate,
and late (L) RNA was harvested 24 hours post infection. A labeled
probe spanning the m l42 and ml43 gene region (Sstl-Sstl) of MCMV
Hind III I was used to detect transcripts from this region (see figure 6).
The 3.8 kb transcript corresponds to m l43; the 1.8 kb transcript
corresponds to m l42 (Hanson et al., 1999).

times (Messerle et al., 1991; Keil et al., 1987; Koszinowski, 1986). This suggests that
unlike IE1 and IE3, m l42 and m l43 proteins may have important functions not only at
immediate early times, but at all stages o f viral infection.
The expression kinetics o f m l42 and ml43 are most like the immediate early
genes IRS1/TRS1 and UL36-38 o f HCMV. In HCMV, the IRS1/TRS1 and UL36-38
genes are expressed in the presence o f anisomycin. These genes are also abundantly
expressed in the presence o f phosphonoacetic acid (Romano wski and Shenk, 1997,
Tenney and Colberg-Poley, 1991a, Tenney and Colberg-Poley, 1991b). The IRS 1/TRS1
and UL36-38 proteins are involved in ori lyt dependent replication o f HCMV, and
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function as transcriptional transactivators. Interestingly, genes m l42 and ml43 have
homology to the HCMV IRS1/TRS1 genes (Rawlinson et al., 1996) suggesting that m l42
and mI43 gene products may have a similar function.

Characterization of pm l42 and pm l43
Generation o f m !42 and m!43 Polyclonal Antibodies. The above experiments
indicated that m l42 and m l43 are tme immediate early genes in that their transcripts are
expressed in the absence o f de novo protein synthesis. It was logical to assume that their
protein products are also expressed at immediate early times, and like the transcripts, are
upregulated at early and late times. Therefore, we proceeded to characterize the
expression o f the m l42 and ml43 gene products in MCMV infected fibroblasts. In order
to do this, antibodies specific for ml42 and m l43 protein products were generated. To
serve as an immunogen for production o f the polyclonal antisera, histidine tagged fusion
proteins were made as bacterially expressed proteins. The pBADHisA vector
(Invitrogen, Carlsbad,CA) was used to generate these fusion proteins. This vector allows
the m l42 and m l43 protein products to be fused to six histidine residues which comprise
a polyhistidine tag and the Xpress epitope. The polyhistidine tags allow purification of
the recombinant fusion protein on a metal-chelating resin and the Xpress epitope permits
detection o f the recombinant fusion protein by the anti-Xpress antibody. This vector also
allows the expression o f the proteins to be strictly regulated. Expression from the
plasmid pBADHis A only occurs in the presence o f arabinose.
In order to generate histidine tagged m l42 and m l43 proteins, the 142 and 143
genes were cloned into the pBADHis A vector. A K pnl-B srG l fragment (nucleotide
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sequences 200526-198878) o f the Hind HI I genomic region o f MCMV was cloned into
pBAD/His A in order to express a portion o f m l42 (Fig. 6). This construct does not
include the first 222 bases o f the m l42 gene, and was called ml42pBAD/HisA.
Remaining in this construct are US22 motifs III and IV within m l42, as well as the acidic
domains (Fig. 5). A K pnl-K pnl fragment o f the Hind III I genomic region of MCMV
(nucleotide sequences 202422-200526) (Fig. 6) was cloned into the pBAD/His A vector
in order to express a truncated m l43 protein. The truncated ml43 gene is missing 171
bases from the 5’ end. This construct, which was called ml43pBAD/HisA, includes the
putative US22 family motifs I, HI and IV, the nuclear localization signals, and the Nglycosylation sites within the m l43 open reading frame (Fig. 5). These constructs were
tested by restriction enzyme digestion to confirm that the correct MCMV sequence was
inserted, and that the MCMV sequence was in the proper orientation.
Next it was necessary to determine if the recombinant m l42 and m l43 proteins
were expressed from their respective expression vectors and to determine the optimal
concentration o f arabinose needed for their expression. In order to do this,
ml42pBAD/HisA and ml43pBAD/HisA were transformed into TOP 10 E. coli. Next
various arabinose concentrations were used to determine if protein expression was
induced from these vectors. According to the DNA sequence, the expected size for the
m l42 recombinant protein was 44 kD. At an arabinose concentration of 0.2 %, a protein
o f 42 kD was expressed from the ml42pBAD/HisA vector (Fig. 9). The predicted size
for the histidine tagged m l43 was 59 kD. At arabinose concentrations of 0.002% and
0.02%, a 56 kD protein was induced from the ml43pBAD/HisA vector (Fig. 9). These
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data indicate that the histidine tagged m l42 and m l43 proteins are expressed from their
respective expression vectors and are similar to their expected size.

his 142
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Arabinose ^
cone:

®\° o\a
^

hisl43
. .

^ ^ ^
v
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FIG. 9. Expression of the histidine tagged recombinant m l42 and ml43 proteins.
Top 10 E.coli containing ml42BAD/HisA or ml43BAD/HisA were incubated
with various arabinose concentrations. The bacterial pellet was then lysed and
analyzed by Western blot as described in the Materials and Methods using the
Anti-Xpress Antibody. Sizes o f molecular weight markers are indicated on the
right.

Since the histidine tagged m l42 and m l43 proteins were expressed from their
respective expression vectors, our next goal was to purify these proteins from bacterial
cells. In order to do this, 250 ml cultures o f bacteria containing ml42pBAD/HisA and
ml43pBAD/HisA were grown, induced with arabinose, and used for recombinant protein
purification. Several attempts were made to purify the recombinant ml42 and ml43
proteins from the bacterial lysate using the Invitrogen Xpress Purification System. This
method was unsuccessful at first because the m l42 and m l43 recombinant proteins
proved to accumulate in inclusion bodies that were discarded with the bacterial debris.
Inclusion bodies are very dense aggregates of insoluble protein that contain most o f the
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expressed protein. O ur next approach was to lyse the cells, purify the inclusion bodies,
solubilize the inclusion bodies, and then purify the recombinant protein. The cells were
lysed and the inclusion body was purified using the B-PER Bacterial Protein Extraction
Reagent (Pierce, Rockford, IL). This reagent allows gentle and complete lysis o f the
bacterial cells, and purification o f the inclusion bodies. The inclusion bodies were then
solubilized using the Inclusion Body Solubilization Reagent (Pierce). The Inclusion
Body Solubilization Reagent moves the insoluble inclusion body into solution, thus
allowing purification o f the recombinant protein. Finally the proteins were purified using
the Xpress Purification System (Invitrogen, Carlsbad, CA). In this system the
recombinant proteins, which were tagged with six histidines, were purified with a metal
chelating column and then eluted from the column. The polyhistidine tag functions as a
metal-binding site for affinity purification o f the recombinant fusion protein on the metalchelating resin. The eluted proteins were then checked to make sure that m l42 and m l43
proteins were present by Western blot analysis using the anti-Xpress antibody. As
expected, a band o f 42 kD was detected for the histidine tagged m l42 recombinant
protein and a band o f 56 kD was detected for the histidine tagged m l43 recombinant
protein (data not shown). The purified proteins were then sent to Cocalico Biologicals,
Inc. (Reamstown, PA) for rabbit injection. Exsanguination o f the rabbits took place
following a two month period, which included four immunizations with the purified
recombinant protein.
Once the polyclonal antisera were obtained, it was necessary to test them for their
ability to recognize the m l42 and m l43 proteins. MCMV lysates from fibroblast cells
that had been either mock infected or infected for 24 hours with MCMV at an MOI o f 2
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were used to screen the rabbit serum by Western blot analysis for specificity o f the
antibody. Specific bands were seen in the infected cell lysates, but not in the mock
infected cell lysates when both m l42 and m l43 antiserum were used. The m l42 protein
corresponds to a 43 kD band, whereas the m l43 protein corresponds to a 53 kD band
(Fig. 10). The m l42 protein product will be called pm l42 and the m l43 protein product
will be called pm l43. The expected size o f pm l42 according to its DNA sequence is 48
kD, and the expected size o f pm !43 according to its DNA sequence is 64 kD. The 142
and 143 proteins may be smaller than expected due to rapid post translational
modification such as proteolytic processing of the proteins, although there is no evidence
that this is taking place. The m l42 transcript shifts from 1.8 kb to 1.6 kb as time
progresses, suggesting that splicing may occur which could account for the smaller size
o f this protein. However nuclease mapping studies have not yet been done to confirm
this (Hanson et al., 1999). There is also precedence for proteins with a high proportion of
basic or charged amino acids to migrate faster or slower than their actual molecular
weight on a polyacrylamide gel (Takano et al., 1988). Since both pm l42 and pml43
have a high content of charged residues, they could be running faster on the
polyacrylamide gel. This phenomenon could explain why pm l42 and pm l43 appear to
be smaller than expected.
Another approach was used to confirm that the 43 and 53 kd proteins originate
from ORFs m l42 and m l43, respectively. This approach utilizes transient transfection of
m l42 or m l43 expression plasmids into cells, followed by Western blot analysis of cell
lysates using pm l42 and pm l43 antisera to determine ifpm l42 and pm l43 are
recognized. To generate the m l42 and m l43 expression plasmids, the full length m l42
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FIG. 10. m l42 and ml43 polyclonal antisera specifically recognize the pml42
and pm 143 proteins, respectively. NIH 3T3 fibroblast cells were mock infected
(M) or infected with wildtype MCMV (WT) at an MOI o f 2 for 24 hours. Lysates
were then analyzed by Western blot (as described in the Materials and Methods)
using A.) the pm l42 or B.) the pml43 antibody. Sizes o f molecular weight
markers are indicated on the left.

and m l43 genes were cloned into the pCDNA3.1 expression vector using the
polymerase chain reaction (PCR). The vector pCDNA3.1 was used because it is
designed for high level expression of the gene o f interest in mammalian cells. This high
level o f expression is achieved because of the presence of the HCMV major immediate
early gene (UL123) enhancer and promoter. This vector also contains the bovine growth
hormone polyadenylation signal and transcription termination sequence to enhance
mRNA stability. The expression plasmid 142pCDNA contains the m l42 gene and the
expression plasmid 143pCDNA contains the m l43 gene. NIH 3T3 fibroblast cells were
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FIG. I I . m l42 and m l43 polyclonal antisera recognize proteins
expressed from the m l42 and ml43 genes respectively. NIH 3T3
cells were m ock transfected or transfected with a plasmid containing
the m l43 or the m l42 gene using the Cytofectine Reagent (Bio-Rad)
as described in the Materials and Methods. Lysates were then analyzed
by Western blot as described in the Materials and Methods using an
antibody m ixture containing pm 142 and pm 143 antisera. Lysates from
wild type M CM V infected cells (WT) serve as a positive control.

transfected with the expression plasmid 142pCDNA or the expression plasmid
143pCDNA. Lysates from these cells were analyzed by W estern blot using a mixture o f
pm l42 and pml43 antisera. The specificity of the antibodies for the m l42 and ml43
gene products was confirmed. The antibody against pm 142 reacted with a 43 kD protein
product o f 142pCDNA and likewise the antibody against pm 143 reacted with a 53 kD
protein product o f 143pCDNA in transfected cell lysates (Fig. 11). Therefore, the 43 kD
and 53 kD proteins recognized by the pm l42 and pml43 antisera are products of the
m l42 and m l43 genes, respectively.

Kinetics o f the pm 142 and pm 143 proteins. As previously described, the m l 42
and m.143 transcripts are present at immediate early times and remain abundant
throughout infection. Prior to these studies the m l42 and m l43 protein products had not
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been identified. Therefore our next goal was to characterize these proteins. Since the
142 and 143 transcripts are present at EE, E, and late times, we also expected to see their
respective protein products at immediate early, early, and late times. To determine if this
occurs, a time course experiment was done in which fibroblast cells were infected with
wild type MCMV at an MOI of 2 for 0, 3, 6, 12 and 24 hours. These lysates were
analyzed by Western blot using a mixture o f pm l42 and pml43 antibodies. The results
are shown in Figure 12. The m l42 protein product (43 kD) was present at 3 hours post
infection as expected, although at low levels. The levels increased between 3 and 6 hours
post infection, and remained abundant at 12 and 24 hours post infection. To our surprise,
it was found that pm 143 (53 kD) was not detected at 3 hours post infection as expected
for an IE protein, even after a prolonged exposure o f film. However after increasing the
MOI to 5 in subsequent experiments, pm 143 was also readily detectable at 3 hours post
infection (see below). Therefore, these proteins appear to be regulated with similar
kinetics.
The kinetics o f pm l42 and pm!43 expression is very different from that o f the
MCMV IE1 and IE3 proteins. The IE1 and IE3 proteins are present by 2 hours post
infection and then gradually decrease at 4, 8, 12, 16 and 24 hours post infection (Messerle
et al., 1992). At the protein level, pm l42 and pm l43 are most similar to the HCMV
immediate early proteins IRS 1/TRS1. These proteins are expressed at 2 hours post
infection and remain throughout the entire HCMV replication cycle at relatively high
levels (Romanwoski and Shenk, 1997). The IE proteins IRS 1/TRS 1 function at early
times as transcriptional
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FIG. 12. Kinetics o f pm !42 and pm l43 protein expression. NIH 3T3
fibroblast cells were infected with wild type MCMV at an MOI o f 2 for
0, 3, 6, 12, and 24 hours. Lysates were analyzed by Western blot as
described in the Materials and Methods using a mixture containing both
pm l42 and pml43 antibodies. Asterisks denote low levels o f pm l42
expression.

transactivators of genes required for viral DNA replication. This potential function will
be considered for pm 142 and pm 143.

pm 142 and pm 143 are not immediate early proteins. Proteins pm 142 and pm 143
were expressed at 3 hours post infection. Therefore they were expressed at a time that is
at the borderline between an immediate early protein and an early protein. The
designation immediate early or early cannot be assigned to pm 142 and pm 143 based on
the time course that was performed previously. This designation can only be assigned to
pm 142 and pm 143 by using drug blocks at specific stages within the viral replication
cycle. To determine if a protein is expressed at immediate early times, cells must first be
infected in the presence o f the protein synthesis inhibitor anisomycin. Under these
conditions only the transcripts that are made in the absence of de novo protein synthesis
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are expressed, the immediate early transcripts. The cells are then washed to remove the
anisomycin, then actinomycin D is added. Actinomycin D prevents additional
transcription o f early genes from occurring. Therefore, only the immediate early
transcripts made previously will be translated into protein, resulting in the expression of
only the immediate early proteins.

T r e a tm e n t:
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Anm /ActD
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FIG. 13. Immediate early genes m l42 and m l43 do not encode detectable
immediate early proteins. NIH 3T3 fibroblast cells were incubated in the
presence o f 100 pM anisomycin (Anm) for one hour, then mock infected
(M) or infected with wild type MCMV (WT) for 3 hours at an MOI o f 5 in
the presence o f 100 pM anisomycin. The cells were then washed with PBS,
then incubated in the presence of 10 pg/ml o f actinomycin D (ActD) for 6
hours. The lysates were harvested and analyzed by Western blot using an
antibody mixture containing both pm 142 and pm 143 antibodies. Lysates
from cells infected in the absence o f drugs serve as a positive control. As
a control to confirm the drug blocks were effective, the Anm/ActD lysates
were also probed with the IE 1 antibody. The IE 1 antibody was kindly provided
by Ulrich Koszinowski (Department of Microbiology, Federal Research
Center for Virus Diseases in Animals, Federal Republic o f Germany).

We wanted to determine if pm l42 and pml43 are immediate early proteins. In
order to do this, NIH 3T3 cells were incubated for an hour in the presence o f lOOpM
anisomycin. Next these cells were either mock infected or infected with MCMV at a
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MOI o f 5 in the presence o f IOOjjM anisomycin for 3 hours. The cells were then washed
with PBS, and incubated in the presence o f 10 pg/ml of actinomycin D for 6 hours. The
lysates were harvested and analyzed by Western blot using an antibody mixture
containing both pm l42 and pm l43 antibodies. Neither pm l42 nor pml43 was detected
in this assay (Fig. 13). The immediate early protein IE1 was detected under these
conditions, although at low levels. By definition, pm 142 and pm 143 are therefore
classified as early proteins. Since pm 142 and pm 143 were present at 3 hours post
infection in the protein kinetics experiment, which is borderline between IE and E, these
data were not surprising.
The MCMV immediate early proteins IE 1 and IE3 should be expressed at
abundant levels under the conditions described above (anisomycin/actinomycin D).
Since the immediate early transcripts were allowed to accumulate in the presence of the
anisomycin, the level o f IE protein should be more abundant in the drug treated cells
(anisomycin/actinomycin D), than cells not treated with drugs. Since the levels o f IE I in
the anisomycin/actinomycin D treated lysates were very low, this indicates that a
technical problem may have occurred with this assay. For example, it is possible that the
anisomycin was not completely removed. To assess this, lysates from cells infected in
the absence o f drugs should be used as a control in future experiments.
Our results have shown that genes m l42 and m l43 express RNA at immediate
early times of viral infection. However, pm 142 and pm 143 are expressed at early times.
Therefore we hypothesize that there is translational control o f m l42 and m l43 RNA.
One possible reason for translational regulation of pm 142 and pm 143 is that the proteins
may be needed immediately following IE protein expression. The presence o f the m l42
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and m l43 transcripts at IE times could allow the rapid synthesis of these proteins at early
times, without the need for m!42 and ml43 transcription.

Localization of the pm l42 and pm l43 proteins
As previously stated m l42 and m l43 are immediate early genes that encode early
proteins, and are members o f the US22 gene family o f HCMV. Although the function of
most US22 gene family members is unknown, certain members of the family encode
transcriptional transactivators. Also, m l42 and m l43 are homologous to the IRS 1/TRS 1
proteins o f HCMV, and are regulated similarly to IRS 1/TRS 1. IRS 1/TRS 1 are involved
in the regulation o f genes active during viral DNA replication. Therefore, it is likely that
pm l42 and pm l43 are transcriptional transactivators. In order for pml42 and pm l43 to
be transcriptional transactivators, they need to localize to the nucleus. Sequence analysis
suggests that this is possible for at least pml43, because pm l43 has several nuclear
targeting signals. In contrast, pm 142 does not contain any nuclear localization signals
(Fig- 5).
Localization of viral proteins in an MCMV infected cell can be tested in several
different ways, for example by immunofluorescence studies. In this case, infected cells
are fixed to glass slides then stained with a primary antibody against the protein of
interest. Next the primary antibody is replaced with a secondary antibody that will
recognize the primary antibody. The secondary antibody is conjugated to a label such as
fluorescein isothiocyanate (FITC). This FITC label will provide a colored reagent that
can be observed directly under a fluorescent microscope. Alternatively, the protein o f
interest can be fused to the green fluorescent protein (GFP). In this case GFP serves as a
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reporter molecule for monitoring protein localization in transfected cells in vitro, since
the protein fluoresces green when exposed to ultraviolet light. It is possible however that
the GFP molecule may mask any nuclear localization signals or alter the structure o f the
protein o f interest, thus interfering with the localization of the protein. Other viral
proteins that may be important in the localization o f the protein of interest may be absent
when using GFP-fiision proteins. This limitation can be overcome however by doing
transfections with the GFP fusion plasmid, followed by superinfection with MCMV.
Lastly, localization of viral proteins can be tested by performing cell fractionation
experiments. In these experiments the nuclear fraction o f a cell is separated from the
cytoplasmic fraction. These fractions are then analyzed by Western blot using an
antibody against the protein of interest to determine localization o f the protein.
We decided to use immunofluorescence to determine the localization o f the
pm 142 and pm 143 proteins. Immunofluorescence is a very powerful tool, since it allows
the localization of the protein o f interest to be determined while maintaining the integrity
o f the infected cell. NIH 3T3 cells were infected with wild type MCMV at an MOI o f 5
for 6 hours or 24 hours. Following infection, the cells were fixed with paraformaldehyde
then stained with pml42 or pml43 antiserum as the primary antibody (Fig. 14A,B). As a
positive control, the antibody against e l, a nuclear localized protein, was used (Fig. 14D).
Rabbit preimmune serum was used as a negative control (Fig. 14C). Following primary
antibody staining, FITC conjugated goat anti-rabbit antibody was used as the secondary
antibody (see Materials and Methods). There was no e l, pm 142 or pm 143 antibody
signal observed when cells were infected for 6 hours (data not shown). This is
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FIG . 14. Immunofluorescense analysis of the pm !42 and pm l43.
NIH 3T3 fibroblasts were infected with MCMV at an MOI o f 5 for
24 hours. Immunofluorescent staining was performed as described
in the Materials and Methods using A. pm!42 antibody or B. pm 143
antibody. As a negative control (C.) preimmune serum was used. As
a positive control (D.) e l antibody was kindly provided by Dr. Gina
Ciocco-Smitt (Department o f Microbiology and M olecular Cell Biology,
Eastern Virginia Medical School, Norfolk, VA).
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likely due to the fact that not enough viral protein was present in the infected cell at 6
hours post infection to be detectable in this assay. However at 24 hours post infection,
the pm 142 protein localized predominantly to the cytoplasm, although low levels o f
pm l42 protein were present in the nucleus (Fig. 14A). It was shown that pm.143 also
localized to the cytoplasm predominantly, with very small amounts in the nucleus (Fig.
14B). Although the presence o f low levels of nuclear pm l42 and pml43 were not
obvious in figure 14, it was more visible in the cross-sectional images of the infected
cells (data not shown). The cross-sectional images allow the cells to be viewed at
different depths or sections, thus allowing the nucleus to be viewed without interference
from the cytoplasmic components. Figure 14 is a representative picture of all o f the
sections combined, therefore the nuclear staining that was observed may not be evident in
this image.
We also used cell fractionation experiments to determine the localization o f
pm 142 and pm 143. These experiments allow the nuclear and the cytoplasmic fraction of
infected cells to be separated and analyzed by Western blot with antisera against the
protein of interest. This allows the localization o f the protein to at least the nuclear or the
cytoplasmic fraction to be determined. For the cell fractionation experiments, NIH 3T3
fibroblast cells were infected with MCMV at an MOI o f 5 for 3 and 4 hours. Then the
NE-PER Nuclear and Cytoplasmic Extraction Reagent was used (Pierce, Rockford, IL) as
described in the Materials and Methods. It was determined that pm!42 localizes to both
the nucleus and the cytoplasm at 3 and 4 hours post infection, and it appears that there is
approximately equal distribution of pml42 in both fractions (Fig. 15A). Although in the
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FIG. 15. pm 142 and pm 143 proteins localize to the nucleus and the cytoplasm
at 3 and 4 hours post infection. A). NIH 3T3 fibroblast cells were infected with
MCMV at an MOI of 5 for 3 or 4 hours. The NE-Per Nuclear and Cytoplasmic
Extraction Reagent (Pierce) was used as described in the Materials and Methods
to separate the nuclear (N) and the cytoplasmic (C) fractions of the infected cells.
Lysates were then analyzed by Western blot using an antibody mixture containing
pm 142 and pm 143 antisera. Lysates from unfractionated cells infected with
MCMV for 24 hours served as a positive control. B). The infected cell lysates
from above were analyzed by Western blot using the phosphotyrosine
phosphatase (PTP) antibody to assess nuclear contamination by the cytoplasmic
fraction.
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kinetics experiment described previously pm 143 was not detected when cells were
infected with an MOI o f 2 for 3 hours, when the MOI was increased to 5 in this
experiment, pm!43 was readily detected at 3 and 4 hours. Increasing the MOI likely
increased the expression levels o f the 143 protein, and therefore assisted in its detection.
The pm l43 protein also localized to both the nucleus and the cytoplasm at approximately
equal amounts at 3 and 4 hours post infection (Fig. ISA). As a control to detect the
degree o f contamination o f the nuclear fraction with the cytoplasmic fraction, the
phosphotyrosine phosphatase antibody was used to analyze these lysates. The
phosphotyrosine phosphatase protein localizes specifically to the cytoplasm. Since the
phosphotyrosine phosphatase protein was present almost exclusively in the cytoplasmic
fraction, this confirms that minimal cytoplasmic contamination o f the nuclear fraction
occurred (Fig. 15B).
In parallel to the immunofluorescence studies, we wanted to determine pm 142
and pm l43 localization at 24 hours post infection. Both pm !42 and pml43 were found
in the nuclear and cytoplasmic fractions at 24 hours post infection (Fig. 16A) It appears
that more pm l42 and pml43 protein was present in the cytoplasmic fraction than the
nuclear fraction, since equal representative volumes o f each sample were analyzed by
Western blot. Also the control protein phosphotyrosine phosphatase localized
predominately to the cytoplasm, suggesting that minimal cytoplasmic contamination o f
the nuclear fraction occurred (Fig. 16B).
In summary, cell fractionation studies have shown that both pm 142 and pm 143
localized to the nucleus and the cytoplasm at 3, 4, and 24 hours post infection. With the
immunofluorescence studies, it was shown that at 24 hours post infection pm 142 and
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pm 143 localized predominantly to the cytoplasm, with low levels o f pm 142 and pm 143
nuclear protein. Our next goal was to determine the ability o f pm l42 and/or pml43 to
transactivate several MCMV promoters. Since pm l42 and pm l43 are early proteins, we
will determine their ability to activate the expression o f the early el gene that is involved
in viral DNA replication (Pari and Anders, 1993). We will also investigate the ability o f
pm 142 and pm 143 to activate the MCMV immediate early promoter.
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FIG. 16. pm l42 and pm l43 localize to the nucleus and the cytoplasm at 24 hours
post infection. A.) NIH 3T3 fibroblast cells were mock infected or infected with
wild type (WT) MCMV at an MOI of 5 for 24 hours. The NE-Per Nuclear and
Cytoplasmic Extraction Reagent (Pierce) was used as described in the Materials
and Methods to separate the nuclear (N) and the cytoplasmic (C) fractions of the
infected cells. The lysates were then analyzed by Western blot using an antibody
mixture containing pm 142 and pm 143 antisera. B). Infected cell lysates from
above were analyzed by Western blot using the phosphotyrosine phosphatase
(PTP) antibody to assess nuclear contamination by the cytoplasmic fraction.
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Functional Characterization of the pm 14:2 and pml43 proteins
We propose that pm !42 and/or pml43 are transcrip tional transactivators. As
previously stated, pm l42 and pml43 are members o f the LFS22 gene family, some o f
which are transcriptional transactivators. Also, pm 142 and. pm 143 are homologous to the
IRS 1/TRS 1 proteins o f HCMV (Rawlinson et al., 1996), amd are regulated similarly to
IRS 1/TRS 1. IRS 1/TRS 1 are involved in the regulation o f g e n es active during viral DNA
replication (Pari ayd Anders, 1993; Pari et al. 1993; Iskend«erian, 1996; Kerry et al.,
1996). According to the cell fractionation experiments and! immunofluorescence
analysis, the pm l42 and pm l43 proteins also localize to th e nucleus (Fig. 14A, 14B, 15A,
16A). Therefore we next determined the transactivation capabilities of pm 142 and
pm 143 collectively and individually.
These studies commenced immediately after the m il42 and m l43 transcripts were
identified as immediate early RNAs, but prior to the analys-is o f their gene products.
Since the m l42 and m l43 transcripts were immediate e arly , we reasoned that their
protein products are likely expressed at immediate early tinnes as well. The other
immediate early proteins o f MCMV (IE1, IE3, and IE2) a r e involved in the regulation o f
the MCMV major immediate early promoter and enhancer ■(MIEPE). The MCMV IE I
and IE2 proteins positively regulate the MIEPE, while IE3 represses expression from this
promoter/enhancer (Koszinwoski et al., 1986; Messerle et a l., 1992; Cardin et al., 1995).
Therefore, we began our analysis of ml42 and m l43 functLon by investigating the ability
o f pm l42 and pm l43 to enhance activation o f the MIEPE Q el/ie3 promo ter/enhancer).
For these studies, the vector MCMV3CAT (M IEP-CA T) was kindly provided by
Dr. Martin Messerle (Department of Virology, University o f Ulm, Germany) (Messerle
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FIG. 17. Schematic representation of the promoter/enhancer regions used in
transient assays. A. Schematic representation o f the MCMV IE
enhancer/promoter (M l22-123) used in the transient assays. Structural
organization o f known consensus binding sites for cellular transcription factors,
repeat elements, restriction enzyme sites and TATA box are shown (DorschHasler et al., 1985; Sanford and Bums, 1996). B. Sequences of the el
enhancer/promoter (Ml 12-113) used in transient assays. Structural organization
o f the predicted consensus binding sites for cellular transcription factors.
Restriction enzyme sites are denoted.

et al., 1992). This vector contains the entire MCMV major IE enhancer and promoter
(M122-123) upstream o f the chloramphenicol acetyl transferase gene (CAT). This
enhancer/promoter region (MCMV sequences 182851-184237) includes all of the known
MIEPE transcription factor binding sites and repeat elements (Fig. 17A) The CAT gene
serves as a reporter that allows the amount of transactivation to be determined by CAT
assay.
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FIG. 18. Description o f m l42/m l43 plasmids used in transient assays.
A. Structural organization o f the m l42-m l43 gene region. Location o f the
promoter sequences (Pro) are depicted by black boxes and restriction enzyme
sites are denoted (B; BsrG). Numbers refer to nucleotides within the MCMV
genome. B. Map o f plasmid inserts containing m l42 and/or m 143 used in
transient assays. C. Map o f pCDNA3.1 vector (Invitrogen) that was used to
express m l42 and/or m l43 proteins. Broken lines depict the location in which
these genes were cloned (multiple cloning site).

Expression of pm 142 and pm 143 from the plasmid 142/143pCDNA3.1. To
determine if the pml42 and pm l43 proteins activate the MCMV MIEPE, a plasmid was
generated to express the m l42 and m l43 genes collectively. The m l42 and m l43 genes,
along with their native promoters, were cloned into the expression vector pCDNA3.1
(Invitrogen) as described in the Materials and Methods. This construct includes MCMV
sequences 198878-203538, and contains the entire m l42 and m l43 open reading frames
with their native promoters and polyadenylation signal (Fig. 5, 6A.). The construct that
contains both m l42 and m l43 was called 142/143pCDNA (Fig. 18B.). The pCDNA3.1
vector contains the HCMV major immediate early promoter/enhancer (FIG 18C.), which
appears to be necessary for optimal expression o f pm l42 and pm 143 from these
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FIG. 19. Proteins pm l42 and pmL43 are expressed from the plasmids
142/143pCDNA, L42pCDNA and I43pCDNA. A. NIH 3T3 fibroblasts were
transfected with 1, 3, 5, 7, or 10 pg o f 142/143pCDNA. The cells were then
harvested after 48 hours and analyzed by Western blot using a pmI42 and pm 143
antibody mixture. B. NIH 3T3 fibroblast cells were transfected with 2, 3, 5, or 7
pg o f 142pCDNA or 143pCDNA as indicated. Lysates from cells infected with
wild type MCMV serve as a positive control. Cell lysates were harvested at 48
hours and analyzed as described above. Asterisks denote low levels o f protein
expression

sequences, since a vector lacking the HCMV MIEPE did not express pm l42 and pml43
to detectable levels by Western blot analysis.
The 142/l43pCDNA vector was tested in transient assays to make sure that
pm 142 and pm 143 proteins were expressed from this vector. NIH 3T3 fibroblast cells
were transfected with 1, 3, 5, 7, and 10 pg of 142/143pCDNA. The pm l42 and pml43
proteins were not detected when 1, 3, or 5 pg o f 142/143pCDNA were transfected (FIG.
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19A.). However, the pm 142 and pm 143 proteins were detected when at least 7 pg of
DNA was transfected, although the levels o f protein were very low (Fig. 19 A.). These
promoters may require other viral proteins for efficient activity. This could also be
explained by expression o f pm l42 and pm.143 from their native promoters, which may be
very weak.

Activation o f the iel/ie3 enhancer/promoter by the pm !42 and pm!43 proteins.
The vector 142/143pCDNA was tested in transient transfections to determine if pm 142
and/or pm l43 transactivates the MCMV MIEPE. Various amounts o f 142/l43pCDNA
were transfected into NIH 3T3 cells, along with 1 pg o f the plasmid MIEP-CAT as
described in figure 20. Following transient transfection o f the given constructs, cell
lysates were analyzed by chloramphenicol acetyl transferase assay as described in the
Materials and Methods. When 1.0 pg o f the vector 142/143pCDNA was transfected with
the MIEP-CAT construct, transactivation o f the MCMV MIEPE was minimal (Fig. 20).
However when 2.0 or 3.0 pg o f 142/l43pCDNA was used, the transactivation levels rise
to at least 3 fold above basal levels. Although low levels o f pm 142 and pm 143 were
expressed under these conditions (Fig. 19A), promoter activity was still increased.
Therefore the m l42 and/or m l 43 gene products enhance activation o f the MCMV
MIEPE. We believe that increasing the concentration of 142/143pCDNA increased the
level o f pm l42 and pml43 expression, thus allowing optimal levels o f transactivation to
be obtained. Initially we were not surprised by these results, since it was known that
immediate early gene products activate the MIEP. However, when it was subsequently
determined that pm 142 and pm 143 are early proteins, the interpretation o f these results
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was brought into question, because no other MCMV early proteins have been shown to
activate the MIEP.
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FIG. 20. Activation o f the MCMV immediate early promoter/enhancer (MIEP)
by IE proteins pm l42/pm l43. A total of 1.0 pg o f reporter plasmid
MCMV3CAT (MIEPCAT) was transfected into NIH 3T3 fibroblasts with the
empty vector pCDNA3.1 (lane 1), or with the plasmid 142/143pCDNA at 1.0 pg
(lane 2), 2.0 pg (lane 3), or 3.0 pg (lane 4). The empty vector pCDNA3.1
(Invitrogen) was used to maintain a constant amount o f plasmid DNA per
transfection. Cell lysates were harvested 48 hours post transfection and analyzed
as described in the Materials and Methods. The transfections were done in
duplicate and each experiment was repeated three times. Error bars represent
standard deviations.
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FIG . 21. Both pm l42 and pml43 are required for activation o f the MCMV
immediate early promoter/enhancer (MIEP). A total of 1.0 pg of the reporter
plasmid MCMV3CAT (MIEPCAT) was transfected into NIH 3T3 fibroblasts
with the empty vector pCDNA3.1 (lane 1), or with the plasmids !42pCDNA (lane
2), !43pCDNA (lane 3), 142pCDNA and 143pCDNA (lane 4), 142/l43pCDNA
(lane 5), or pIEl 11 (lane 6). The empty vector pCDNA3.1 (Invitrogen) was used
to maintain a constant amount o f plasmid DNA per transfection. The numbers
denote the amount of plasmid DNA transfected in pg. Cell lysates were
harvested 48 hours post transfection and analyzed as described in the Materials
and Methods. The transfections were done in duplicate and each experiment was
repeated three times. Error bars represent standard deviations.

Expression of pm l42 and pml43 from the plasmid 142pCDNA and 143pCDNA
Since 142/143pCDNA expresses both pm l42 and pm l43, we were not sure which
protein functioned to enhance transcriptional transactivation. Therefore, we wanted to
determined if pm l42, pmI43 or both have the ability to enhance transactivation.
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Expression plasmids containing m l42 and m l43 alone were cloned into pCDNA3.1 as
described in the Materials and Methods. The plasmid 142pCDNA contains the entire
m l42 sequence (MCMV sequences 199412-200517) but not the m l42 promoter. The
plasmid 143pCDNA contains the entire m l43 sequence, but not the m l43 promoter
(MCMV sequences 202602-202626) (Fig. 18B). These plasmids were also tested in
transient assays to determine if pm 142 and pm 143 were expressed from their respective
expression vectors. NIH 3T3 cells were transfected with 2, 3, 5 and 7 pg o f 142pCDNA
or 143pCDNA, and cell lysates were analyzed by Western blot analysis using a pm l42
and pm l43 antibody mixture. Unlike 142/143pCDNA, the levels o f protein expressed
from 142pCDNA and pml43pCDNA were very high. With as low as 2 pg o f
142pCDNA and 143pCDNA, the pm l42 and pm l43 proteins, respectively, were clearly
detectable (Fig. 19A). High levels o f protein expression are likely due to the presence o f
the HCMV MIEP that is located immediately upstream o f the m l 42 and m l 43 sequence.

Both pm 142 and pm!43 are required for transactivation o f the MCMV MIEPE.
In order to determine if pm l42, pm l43 or both has the ability to enhance transactivation
of the MIEPE, the plasmids containing m l42 or m l43 alone (called 142pCDNA or
143pCDNA, respectively) were tested in transient transfection assays along with MIEPCAT. The positive control plasmid expressing both IE1 and IE3 transactivates this
promoter 10 fold above basal levels. However, proteins expressed from neither
142pCDNA nor 143pCDNA transactivated the MIEPE alone (Fig. 21). When the
construct 142/143pCDNA was transfected with the MIEP-CAT construct, transactivation
o f 3-4 fold above basal levels was obtained. Therefore both pm l42 and pm l43 are
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necessary for transactivation o f the MIEPE to occur. To our surprise, when both
142pCDNA and 143pCDNA were transfected together, transactivation o f the MIEPE
above basal levels was not achieved. This could be due to the phenomenon o f
squelching, since the levels o f protein expressed from 142pCDNA and 143pCDNA under
these conditions were very high compared to proteins expressed from 142/143pCDNA
(Fig. 22). It is also possible that a splice variant may be expressed from 142/143pCDNA.
There is some evidence that splicing o f the m l 42 transcript may be occurring since the
size o f the m l42 transcript changes from 1.8 kb to 1.6 kb as time progresses (Fig. 8).
Also an alternate transcript may be expressed from 142/143pCDNA (m l42b, m l42c) that
is not expressed from 142pCDNA or 143pCDNA, and that protein product may act as the
transcriptional transactivator (Fig. 6A).
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FIG. 22. Elevated expression o f pm 142 and pm 143 may have caused squelching
to occur in the MCMV MIEP promoter analysis. NIH 3T3 cells were transfected
with the indicated plasmids. The numbers refer to pg of DNA. Cell lysates were
harvested 48 hours post transfection and analyzed by Western blot analysis using
a pm l42 and pml43 antibody mixture. Asterisks denote location o f proteins.
Last lane includes a darker exposure.
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FIG. 23. The m l 42/m 143 gene products enhance expression from the HCMV
MIEP. NIH3T3 fibroblasts were transfected with an HCMV-MIEP driven
MCMV M140 expression vector (lanes 1 and 3) or cotransfected with the same
construct in addition to the ml42/143 expression vector (lane 2). Cells were
mock-infected (lane 1 and 2) or superinfected with a MCMV triple deletion
mutant (A139-14l)(lane 3). Wild type (WT) infected lysates serve as a positive
control (lane 4). Transfection, superinfection and Western blot analyses were
conducted as described in the Materials and Methods.

m l42 and m l43 gene products can transactivate the HCMV MIEPE. An alternate
approach was used to test the ability of the pm l42 and pm l43 to activate the HCMV
MIEPE. It has previously been shown that the HCMV MIEPE can substitute for the
MCMV MIEP in the context of an MCMV infection (Angulo et al., 1998; Grzimek et al.,
1999). In our laboratory we had a construct containing the MCMV M140 gene under the
control o f the HCMV MIEPE. We reasoned that if pm l42 and pm l43 are able to activate
the MCMV MIEP, they should also be able to transactivate the HCMV MIEP.
Therefore, in the presence o f pm 142 and pm 143, M140 protein expression should be
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increased. We cotransfected a M140 expression plasmid with the 142/143pCDNA
plasmid into NIH 3T3 cells. We then analyzed the lysates for levels o f M140 protein by
Western blot analysis using a M l 40 antibody. Our results show that the levels o f M l 40
were increased when pm 142 and pm l43 were present compared to M140 alone (Fig. 23).
These levels were even higher than those found in cells superinfected with the A139-141
mutant virus that contains the full repertoire o f IE proteins. Therefore, pm 142 and/or
pm 143 are able to transactivate the HCMV MIEPE. These results were not surprising
since it was previously shown that pm I42 and pm 143 transactivated the MCMV MIEPE.
The HCMV and MCMV MIEPE have some sequence homology and therefore pm 142
and pm 143 proteins may function via similar sequences within both the MCMV and
HCMV MIEPE, thus allowing transactivation to occur.

M122-123
177009

184237

,________________________________________ ,
I------------------------------------------------- 1
I............ .................... ............................................... 1

(IE1)
(IE3)
(IE2)
pIEl 11
pIEl
pIE3

FIG . 24. Structural organization o f the MCMV major IE gene loci (M122-123).
Map o f MCMV major immediate early gene region and useful restriction enzyme
sites. The promo ter/enhancer region is denoted by a black box. Also included
are IE transcripts and plasmids used in transient assays (Messerle et al., 1992).
The dotted line denotes deleted sequences and restriction enzyme abbreviations
are as follows: B, Bam Hl; E, EcoRl; A, Aval; M, M scl; Hp, H pal; and H,
Hind 111.
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Lack o f cooperativity between IE1/IE3 and pm l42/pm !43 in the activation o f the
MCMV MIEP (M 122-123). In HCMV and MCMV, it has been shown that the
immediate early proteins can act cooperatively in the activation o f some promoters. We
wanted to determine if pm I42 and pml43 might cooperate with the MCMV IE I protein
in transactivating the MIEP. Therefore, in the next study we used a plasmid that
expresses both IE1 and IE3 proteins (pLE 111). This vector was kindly provided by Dr.
Martin Messerle (Messerle et al., 1992) and is depicted in figure 24. The vector
142/143pCDNA was cotransfected with the MIEP-CAT construct and the plasmid
expressing both LEI and IE3 (pIEl 11). It has previously been shown that 1 pg o f the
IE1/IE3 expressing plasmid (pIEl 11) transactivates the MIEPE to very high levels. The
high levels o f transactivation can be attributed to IE1, which positively regulates the
MIEPE (Kosinowski, 1986). Therefore, in our studies we reduced the amount of pIEl 11
to 0.25 pg, since IE1 is such a potent transactivator o f the MIEPE. We then titrated in
increasing amounts o f 142/143pCDNA. We found that 0.25 pg o f IE1/IE3 alone
transactivated the MIEPE to about 1.6 fold above basal levels (Fig. 25). When
142/143pCDNA was added, the levels of transactivation increased in a dose responsive
manner. With 2.0 pg o f !42/l43pCDNA, transactivation by IE1 and IE3 doubled to
almost 4 fold above basal levels, and with 3 pg of 142/143pCDNA activation of 5 fold by
IE1/IE3 was found. The levels o f transactivation by IE1/IE3 and pm l42/pml43 were
additive, and no cooperativity was observed. These results were not surprising since the
other MCMV immediate early proteins exhibit noncooperative effects on the MIEPE as
well. For example, IE1 alone transactivates the MIEP, while IE3 alone represses the
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FIG. 25. Additive effects between the proteins pm l42/pm l43 and IE1/3 in
activating the MCMV MIEP. A total of 1.0 jag o f the reporter plasmid
MCMV3CAT (MIEPCAT) was transfected into NTH 3T3 fibroblasts with the
empty vector pCDNA3.1 (lane 1) or with plasmids pIEl 11 (IE1 and IE3) and/or
m!42/143pCDNA. The amount o f pIEl 11 DNA was kept constant at 0.25 pg per
sample (lanes 2-5) and !42/143pCDNA was titrated in at 1.0 pg (lane 3), 2.0 pg
(lane 4), 3.0 pg (lane 5) or 3.0 pg (lane 6). The empty pCDNA3.1 vector was
used to maintain a constant amount of plasmid DNA per transfection. Cell lysates
were harvested 48 hours post transfection and analyzed as described in the
Materials and Methods. The transfections were done in duplicate and each
experiment was repeated three times. Error bars represent standard deviations.

MIEP. When IE1 and IE3 are combined, their effects on the MIEP are additive
(Messerle et al., 1992).
In this experiment the level o f transactivation o f the MIEPE by IE1/IE3 and
m l42/m l43 were additive. Since iel and ie3 are under the control of their native
promoter, the MIEPE, in the iel/ie3 expression vector (pIEl 11), it is possible that the
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additive levels o f transactivation by m 142/m 143 and IE1/IE3 result from an increase in
the expression o f IE1. The proteins m l42 and m l43 may cause an increase in IE1
expression from pIEl 11, and IE1 could then transactivate the MIEP-CAT plasmid
resulting in an increase in CAT expression. In order to determine if m l42/m l43 and
IE/IE3 contribute to the activation o f the MIEP-CAT independently in an additive
manner or if m l42/m l43 are increasing LEI expression under these conditions, Western
blot analyses looking at IE 1 levels would have to be done in parallel with the
transactivation studies.

pm!42 and pm!43 fail to activate the early el (Ml 12-113) promoter. Since
pm 142 and pm 143 are early proteins, they likely transactivate genes that are expressed at
early times. Furthermore, pm l42 and pml43 have homology to IRS1-TRS1 o f HCMV.
IRS1/TRS1 have been shown to activate early genes involved in viral DNA replication.
So, we wanted to determine if pm l42 and pml43 are able to transactivate early genes
involved in DNA replication. In these studies we used the early el promoter (M l 12-113)
(Fig. 17B). The e l gene (M l 12-113) encodes nuclear localized proteins that are
homologous to HCMV UL112-113 gene products required for HCMV ori-Lyt dependent
viral DNA replication. The plasmid e 1-CAT was kindly provided by Dr. Martin
Messerle (Messerle et al., 1992) and includes MCMV sequences 160352-162095
upstream of the CAT gene (Fig. 17B). This promoter contains several predicted
consensus binding sites for the cellular transcription factors GM-CSF, AP-1, CRE and
SP1. When NIH 3T3 cells were transiently transfected with 1.0 pg o f the e 1-CAT
construct and 1.0 pg of 142/143pCDNA, there was no transactivation (Fig. 26). When
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FIG. 26. Failure o f the proteins pm 142 and pm 143 to activate the early el
promoter. A total o f 1.0 jag o f the reporter plasmid el CAT was transfected into
NIH 3T3 fibroblasts with the empty vector pCDNA3.1 (lane 1), or with the
plasmid 142/143pCDNA at 1.0 pg (lane 2), 2.0 pg (lane 3), or 3.0 pg (lane 4). As
a positive control the plasmid pIEl 11 (IE1 and IE3) was used (lane 5). The
empty vector pCDNA3.1 (Invitrogen) was used to maintain a constant amount o f
plasmid DNA per transfection. Cell lysates were harvested 48 hours post
transfection and analyzed as described in the Materials and Methods. The
transfections were done in duplicate and each experiment was repeated three
times. Error bars represent standard deviations.

142/143pCDNA was increased to 2.0 pg and 3.0 pg, transactivation still did not take
place. However, the IE1/IE3 proteins were potent transactivators o f this promoter.
Therefore, pm 142 and/or pm 143 do not transactivate the e l promoter alone.
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pm 142 and pm 143 proteins cooperate with IE1 and IE3 to transactivate the el
promoter (M l 12-113). Since IE1 and IE3 act synergistically to transactivate the el
promoter (Messerle et ah, 1992), we wanted to determine if pm l42 and/or pml43 might
enhance this phenomenon. In order to do this, we transfected NTH 3T3 cells with 1.0 pg
o f el-CA T and 0.25 pg o f the iel/ie3 plasmid (pIEl 11), along with various amounts of
142/143pCDNA. We used the concentration o f 0.25 pg o f pIEl 11 since 1.0 pg of
pIEl 11 transactivated this promoter to very high levels (80% acetylation). Although
proteins expressed from 142/143pCDNA did not transactivate el-CAT in the absence o f
other viral proteins, pm l42 and/or pml43 cooperated with IE1/IE3 in transactivating the
e l promoter (Fig. 27). When el-CA T was transfected along with 0.25 pg of the IE1/IE3
expression plasmid (pIEl 11), activation o f about 30 fold above basal levels was
achieved. When 1.0 pg o f the plasmid 142/143pCDNA was added, transactivation
increased to about 40 fold above basal levels. The fold activation continued to increase
as more 142/143pCDNA was added. Therefore, this response was dose dependent.
Activation as high as 80 fold above basal levels was achieved when 3 pg of
142/143pCDNA was added. Therefore pm!42 and/or pm l43 cooperate with IE1/IE3 in
activating the e l promoter. We were very excited about these findings since this is the
first documentation that other MCMV viral proteins assist in IE1/IE3 mediated
transactivation o f the e l promoter or any other promoter.
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FIG. 27. Cooperation between the proteins pm l42/pm l43 and IE1/3 in activating
the early e l promoter. A total o f 1.0 pg of the reporter plasmid elC A T was
transfected into NIH 3T3 fibroblasts with the empty vector pCDNA3.1 (lane 1) or
with plasmids pIEl 11 (IE1 and IE3) and ml42/143pCDNA. The amount of
pIEl 11 DNA was kept constant at 0.25 pg per sample (lane 2-5) and
142/143pCDNA was titrated in at 1 pg (lane 3), 2 pg (lane 4) or 3 pg (lane 5).
The empty vector pCDNA3.1 (Invitrogen) was used to maintain a constant
amount o f plasmid DNA per transfection. Experiments were conducted as
described in the Methods. The transfections were done in duplicate and each
experiment was repeated three times. Error bars represent standard deviations.
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F IG . 28. Both pm 142 and pm 143 are required for maximal cooperation with
IE1/IE3 proteins in the activation of the early e l promoter. A total o f 1.0 pg of
the reporter plasmid elCA T was transfected into NIH 3T3 fibroblasts with the
empty vector pCDNA3.1 (lane 1) or with plasmids pIEl 11 (IE1 and IE3) (lanes 26), 142pCDNA (lane 3), 143pCDNA (lane 4), 142pCDNA and 143pCDNA (lane
5) or ml42/143pCDNA (lane 6). The numbers denote the amount o f DNA added
in pg. The empty vector pCDNA3.1 (Invitrogen) was used to maintain a constant
amount o f plasmid DNA per transfection. Experiments were conducted as
described in the Methods. The transfections were done in duplicate and each
experiment was repeated three times. Error bars represent standard deviations.

Both pm !42 and pm!43 are required for the cooperative activity with IE1 and IE3
in the transactivation o f the e 1 promoter. We went on to determine if pm 142, pm 143 or
both might cooperate with IE 1 and IE3 in activating the e I promoter. In order to do this
we transfected the el-CAT construct and pIEl 11 along with 142pCDNA, !43pCDNA, or
both 142pCDNA and !43pCDNA as shown in figure 28. Unfortunately we do not have
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data from cells transfected with el-C A T and 142pCDNA o r 143pCDNA alone.
Therefore, we can only speculate that proteins expressed from 142pCDNA and
143pCDNA fail to transactivate the e l promoter, like those expressed from
142/143pCDNA. We found that in the presence of pm l42 alone, the activity mediated by
LEI and IE3 doubles. The protein pm l43 however, does not assist IE1/IE3 in the
activation o f the e l promoter. When I42pCDNA and I43pCDNA were transfected
together, transactivation by IE1/IE3 was increased but to levels that were not significant.
However, pm l42 and pm!43 expressed from 142/143pCDNA was found to cooperate
with IE1 and IE3, allowing transactivation o f the MIEP to reach 140 fold above basal
levels. Therefore the co-expression o f the plasmids 142pCDNA and 143pCDNA did not
restore cooperation with IE1 and IE3 to the levels seen with 142/143pCDNA. As
mentioned previously, this can be explained by squelching since there is more pm 142 and
pm l43 expressed from 142pCDNA andl43pCDNA than from 142/143pCDNA under
these conditions (Fig. 29). Also, since the m l42 and m l43 proteins are overexpressed
from 142pCDNA and 143pCDNA, there could be improper localization o f the m l42 and
m l43 proteins. Also, an alternate protein may be made from the 142/143pCDNA vector,
which may contribute to the activation o f this promoter. From these data we can
conclude that both pm 142 and pm 143 act cooperatively with the immediate early proteins
IE1 and IE3, since the proteins expressed from 142/143pCDNA dramatically increased
the activation seen with IE1 and IE3.
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FIG. 29. Elevated expression o f pm 142 and pm 143 may have caused squelching
to occur in the el promoter analysis. NIH 3T3 cells were transfected with the
indicated plasmids. The numbers refer to pg o f DNA. Cell lysates were
harvested 48 hours post transfection and analyzed by Western blot analysis using
a pm l42 and pml43 antibody mixture. Asterisks denote low levels o f protein
expression.

Summary o f transactivation results. Proteins pm 142 and pm 143 were able to
transactivate the MCMV MIEPE in a dose dependent manner to at least 3 fold above
basal levels, and both proteins were necessary for transactivation to occur. These
proteins were also able to transactivate the HCMV MIEPE. However, pm l42 and pm 143
proteins exhibited noncooperative effects with IE1/IE3 in the activation of the MCMV
MIEPE. Collectively pm l42 and pm l43 failed to activate the early el promoter.
However when in combination with IE1 and IE3, cooperative activity by pm!42 and
pm 143 was observed in the activation o f the el promoter. Although pm 142 alone
assisted IE1 and IE3 to some degree, both pm 142 and pm 143 were required for optimal
activity.
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CHAPTER V
DISCUSSION
Kinetics of m l42 and m l43 RNA Expression
MCMV genes m I42 and mL43 are required for replication in NIH 3T3 fibroblast
cells. Therefore, these genes are essential and play a very important role in the biology o f
MCMV. The gene m l42 includes MCMV sequences 199444-200748, and the gene
m l43 includes MCMV sequences 200923-202593. The m l42 transcript is 1.8 kb in size
and the 5’ end o f the transcript has been mapped to MCMV sequences 200847 or 200848.
The m l43 transcript is 3.8 kb in size and the 5’ end o f the transcript starts at MCMV
sequences 202694 or 202686 (Fig. 5, 6). Both m l42 and m l43 are transcribed at
immediate early times, and their steady state levels increase and remain abundant at early
and late times. In addition to the m l42 and m l43 transcripts, several unexpected
transcripts were expressed from the m l42-m l43 gene region at early and late times.
These unexpected transcripts are 1.6 kb and 2.2 kb in size (Fig. 8). The 1.6 kb transcript
may result from splicing o f the 1.8 kb m l42 transcript. However, nuclease mapping
studies would have to be done to confirm this. The 1.6 kb band could also be an early
transcript containing another potential ORF within m l42, designated ml42b.
Alternatively, the 1.6 kb transcript may result from a shorter poly (A) tail of the 1.8 kb
transcript. A similar type o f regulation has been observed for the HCMV iel transcript
(Stamminger, 1991). The 2.2 kb transcript most likely contains ORF ml42c, however
the mapping o f the 5’ end o f the 2.2 kb transcript has not yet been done (Fig. 6).
Therefore, more extensive mapping is needed in this region to confirm the origin o f the
1.6 kb and 2.2 kb RNAs and to determine if splicing occurs in this region.
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The expression pattern o f m l42 and m l43 is different from the expression o f the
other MCMV immediate early genes. The immediate early genes iel and ie3 are
expressed at abundant levels at IE times. However, they are not expressed at early and
late times o f viral infection. The expression kinetics o f m l 42 and m l 43 RNAs are quite
similar to HCMV immediate early genes LRS1/TRS1, which are required for the
activation o f early genes involved in HCMV viral replication. IRS 1 and TRS1 transcripts
are present at immediate early, early and late times. Interestingly, m l42 and m l43 also
have homology to IR S l/T R S l. This suggests that, unlike iel and ie3, m l42 and m l43 are
similar to IR Sl/TR Sl in that they likely have important functions at early and late times
o f viral infection. In our studies, we have shown that m l42 and m l43 do in fact have
functional similarity to IR Sl/T R Sl, by cooperating with IE1/IE3 in the activation o f an
early gene.

Characterization of pm l42 and pml43
The m l42 and m i43 protein products (designated pm 142 and pm 143,
respectively) were characterized according to size, kinetics and location within an
MCMV infected cell. According to the DNA sequence, the expected size for the m l42
protein product was 48 kD, and the expected size for the m l43 protein product was 64
kD. However these proteins proved to be smaller than expected. The m l42 protein
corresponds to a 43 kD protein product and the m l43 protein corresponds to a 53 kD
protein product (Fig. 10). These protein products may be smaller than expected due to
proteolytic processing o f the proteins. However, since there was no variation in the sizes
o f the m l42 and m l43 proteins as the infection progressed, this is unlikely (Fig. 12).
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Splicing o f the m!42 transcript could also be taking place since the m l42 transcript shifts
from 1.8 kb to 1.6 kb as the viral infection progresses, possibly resulting in a shorter
ORF. There is also precedence for proteins with a high proportion of basic or charged
amino acids to migrate faster or slower than their actual molecular weight on a
polyacrylamide gel (Takano et al., 1988). Since both pm l42 and pml43 have a high
content o f charged residues, they could be running faster on the polyacrylamide gel.
Because the sizes o f pm 142 and pm 143 are smaller than expected, it is likely that no
major posttranslational processing like phosphorylation or glycosylation is taking place
although m l43 has two potential N-glycosylation sites.
The proteins pml42 and pml43 were expressed differently from the MCMV IE1
and IE3 proteins. The LEI and IE3 proteins are present by 2 hours post infection, and
then gradually decrease. These proteins (IE1 and IE3) are not detectable at early and late
times. The pm l42 and pml43 proteins, however, were detectable at 3 hours post
infection and increased as the viral infection progressed (Fig. 12). Interestingly, the
kinetics o f pm !42 and pm!43 expression (like their RNA) was similar to IRS 1/TRS1.
IR Sl/TR Sl are expressed at 2 hours post infection and remain throughout the entire
HCMV replication cycle at relatively high levels (Romanowski and Shenk, 1997).
However unlike IRSl/TRSl, pm 142 and pm 143 are not expressed to detectable levels
under conditions in which only the immediate early proteins are expressed. Therefore,
the m l42 and m l43 protein products cannot be designated as immediate early proteins.
However, since Western blot analyses are not very sensitive assays, it is possible that
pm 142 and pm 143 are present at IE times, but not to levels that are not detectable by this
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method. To address this, we could perform 35S labeling o f infected cells followed by
immunoprecipitations using pm 142 and pm 143 antisera.
It was surprising to find that the m!42 and m l43 genes, which are immediate
early genes, expressed their protein products at early times (Fig. 13). Since this occurs,
there is likely control o f m l42 and ml43 at the level o f translation. This control can be
mediated by sequences at the 5’ untranslated region (UTR) or the 3’ UTR o f the m l42
and m l43 transcript. For example, the HCMV UL99 gene is regulated by leader
sequences (Kerry et al., 1997), having secondary structure that interferes with the
scanning o f the ribosomal preinitiation complex (Gray and Wickens, 1998). Other CMV
genes can be regulated at the level o f translation by short ORFs. The CMV UL4 gene
contains a 22 codon upstream ORF, whose protein product represses downstream
translation by blocking translational termination at its own stop codon, thus causing
ribosomes to stall on the mRNA (Alderete et al., 1999).
It is possible that m l42 and ml43 are regulated by secondary structure at the 5 ’
UTR or short ORFs. The former is not likely because algorithmic analyses predict the 5’
UTR o f m l 42 and m l 43 to be moderately stable, and therefore secondary structure at the
5’UTR should not inhibit migration of the ribosomal subunit. The stem loop structure of
the m l42 5 ’ UTR was calculated to have an optimal standard free energy value (AG) o f
about -32 Kcal/mole. The stem loop structure o f the ml43 5’ UTR was calculated to
have an optimal standard free energy value (AG) o f about —30 Kcal/mol. Stem loop
structures that inhibit translation usually have an optimal standard free energy value of
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-50 Kcal/mol or lower (Kozak, 1989). However, this does not rule out the involvement
o f other cellular or viral proteins that may bind to sequences within the 5’ UTR and
hinder the progression o f the preinitiation complex.
It is possible that translation o f m l42 and ml43 mRNA is regulated by a short
open reading frames contained in the m l42 5 ’ UTR (Fig. 6). The protein product o f this
ORF could be involved in the repression o f m l42 or ml43 protein expression. However,
analysis o f the 5’ end revealed no ORF in this region. It is also possible that sequences at
the 3 ’ UTR o f m!42 and m l43 can regulate translation by changing poly (A) tail length
or by making contacts with the proteins involved in translational initiation (Gray and
Wickens, 1998).
Since the m l42 and m l43 proteins were expressed during early times, they likely
have important functions during this time in the viral replication cycle. Therefore, these
genes could be involved in 1) viral pathogenesis or host immune evasion, 2) viral DNA
replication or the regulation o f genes involved in viral DNA replication or 3) the
regulation o f the major immediate early promoter and enhancer (MIEPE) by functioning
similarly to the virion tegument proteins that have transactivating activity. We
investigated the role pm l42 and pm l43 play in the regulation o f the MIEPE and the
regulation o f an early gene involved in viral DNA replication. Our results show that
pm 142 and pm 142 regulate the MIEPE and the promoter o f at least one early gene
involved in MCMV DNA replication.
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Intracellular Localization o f pm l42 and pml43
Most viral regulatory proteins are nuclear proteins that bind promoter/enhancer
sequences or interact with cellular transcription factors. However, viral proteins located
outside the nucleus can also regulate gene expression. For example, the UL37 protein is
an integral membrane glycoprotein that traffics through the endoplasmic reticulum and
Golgi apparatus. It is believed that UL37 protein product regulates viral gene expression
via cell signaling (Zhang et al., 1996). However recent studies show that the acidic
domain of UL37 plays a key role in transactivating viral promoters (Colberg-Poley et al.,
1998). Some investigators speculate that the acidic domain o f membrane bound UL37
may be released by proteolytic cleavage, translocate to the nucleus, and regulate gene
expression in the nucleus (Colberg-Poley et al., 1998). Other viral regulatory proteins
have been shown to shuttle between the nucleus and the cytoplasm, and perform different
functions depending on their location. For example, the Tax protein of human T-cell
leukemia virus type I shuttles between the nucleus and the cytoplasm (Burton et al.,
2000). While in the nucleus, Tax activates the promoters o f viral and cellular genes.
While in the cytoplasm, Tax indirectly regulates NFkappaB. Tax does this by interacting
with the cytoplasmic inhibitor o f NFkappaB, thus allowing NFkappaB to translocate to
the nucleus to regulate gene expression (Li and Gaynor, 1999). So although most
proteins involved in gene regulation are nuclear proteins, we cannot assume that proteins
that localize to the cytoplasm are not involved in the regulation o f gene expression.
The cell fractionation studies have shown that both pm 142 and pm 143 localized
to the nucleus and cytoplasm at 3, 4, and 24 hours post infection (Fig. 14A, 16A). In the
immunofluorescence studies m l42 and m i43 localized predominantly to the cytoplasm at
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24 hours post infection, with low levels o f pm l42 and pm 143 nuclear protein (Fig. 14A,
14B). The difference in the immunofluorescence and cell fractionation results can be
explained by the inherent differences between these two assays. In the cell fractionation
experiments, the cell lysates were analyzed by Western blot under denaturing conditions,
disrupting any protein-protein interactions. In the immunofluorescence studies, the cells
were fixed in paraformaldehyde. Although this fixative preserves the architecture o f the
cell, it may cross-link amino groups on adjacent molecules stabilizing protein-protein and
protein-nucleic acid interactions. If these interactions are taking place in the cell, it is
possible that the antigenic epitopes of pm!42 and pm l43 may be masked. It is also
possible that pm l42 and pm 143 are not present in the nucleus at a density that is
detectable in this assay, or nuclear shuttling may be involved.
In the cell fractionation assays, it also appeared that pm 142 and pm 142 were
present in both the nucleus and the cytoplasm at relatively similar amounts (Fig. 15A,
16A). In the immunofluorescence assays however, most o f the pm 142 and pm 143
appeared to localize to the cytoplasm (Fig. 14A, 14B). The nuclear and cytoplasmic
fractions from the cell fractionation experiments were analyzed by Western blot. Since
the Western blot method has a narrow quantitative range, we cannot assume that pm 142
and pm 143 localize to the cytoplasm and the nucleus at equal amounts in an infected cell.
In order to determine the relative amount o f pm l42 or pm l43 in the nucleus and the
cytoplasm, the cell fractionation experiments can be done using lysates from radiolabeled
MCMV infected cells, followed by immunoprecipitation o f the nuclear and cytoplasmic
fractions with pm l42 or pml43 antisera. The immunoprecipitated samples then can be
run on an acrylamide gel under denaturing conditions, the gel dried, and analyzed on a
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phosphorimager to quantitate the amount o f pm l42 or pml43 in the nuclear versus
cytoplasmic fraction. These results would also indicate if pml42 and pm l43 associate
with other cellular or viral proteins while in the nucleus or the cytoplasm. It is also
possible that pm l42 and pml43 may associate with each other.
MCMV US22 family members located adjacent to m l42 and m!43 in the MCMV
genome form protein-protein interactions (Karabekian, unpublished data). It is likely that
pm l42 and pm l43 also associate, and therefore co-localize in a MCMV infected cell.
The pm 142 and pm 143 proteins are expressed similarly, localize to the same cellular
compartments, and are both needed to enhance expression of several MCMV genes. In
order to determine if pm 142 and pm 143 associate with each other, immunoprecipitation
experiments can be done on MCMV infected cells using pml42 or pm l43 antisera. The
immunoprecipitated samples then can be analyzed by Western blot using pm 142 and
pm 143 antisera. Also, immunofluorecence studies can be done using confocal laser
scanning microscopy to determine if these proteins co-localize. However, both pm 142
and pm 143 antisera were generated in rabbits. Therefore if in the colocalization studies
we use our pm 142 and pm 143 antisera as the primary antibody, followed by anti-rabbit
secondary antibodies, pm 142 will not be distinguished from pm 143. Antisera against
pm 142 or pm 143 must be generated in another animal like the mouse. This will allow a
goat anti-mouse secondary antibody conjugated to a fluorescent molecule like Texas red
to be used to localize pm l42, while a goat anti-rabbit secondary antibody conjugated to
FITC can be used to localize pm 143. Alternatively, either pm 142 or pm 143 antisera can
be directly conjugated to a fluorescent molecule like Texas red. This will enable the
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pm 142 and pm 143 proteins to be distinguished by the confocal microscope since FITC
and Texas red fluoresce at different wavelengths o f light.
As stated previously, pm l42 and pml43 were present in the nucleus and
cytoplasm at early times (3 and 4 hours post infection). Both pm l42 and pm l43 were
also present in the nucleus and cytoplasm at late times (24 hours post infection).
Interestingly, HCMV IRS1 and TRS1 are present in the nucleus and the cytoplasm at
immediate early and early times o f viral infection, however they localize predominantly
to the cytoplasm at late times o f viral infection (Romanowski and Shenk, 1997).

During

a viral infection, HCMV IRS 1 and TRS1 are packaged in the virion and transactivate the
HCMV MIEPE following viral entry into the host cell. These proteins are also involved
in the regulation o f the early replication fork proteins. Since pm l42 and pm l43 have
homology to IR Sl/TR Sl and localize to the nucleus, we went on to determine the
transactivating capability of these proteins by testing their ability to transactivate the
MIEP and an early promoter involved in viral DNA replication.

Transactivation of the Major Immediate
Early Promoter and Enhancer by pml42 and pm l43
The pm 142 and pm 143 proteins transactivated the MCMV major immediate early
enhancer and promoter (MIEPE) 3 fold above basal levels (Fig. 20). Since pm l42 and
pm l43 are early proteins this could occur if 1) pm l42 and pm l43 are packaged in the
virion and transactivate the MIEPE after virion attachment and penetration, or if 2) the
pm l42 and pm l43 proteins transactivate the MIEPE at early times in order to keep IE1
and IE3 protein available for early gene expression. Since IE1 and IE3 protein are not
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expressed in the presence o f phosphonoacetic acid (at early times), the former possibility
is more likely.
HCMV IRS 1 and TRS 1 are packaged in the virion and they transactivate the
HCMV MIEP following viral attachment and penetration. Interestingly m l42 and m l43
have homology to IRS 1/TRS1, and are regulated similarly to IRS 1/TRS1. The proteins
pm l42 and pml43 are also nuclear proteins. Therefore, pm!42 and pm l43 could act as
virion regulatory proteins in a manner similar to IRS 1/TRS 1. According to our
immunofluorescence analysis, pm 142 and pm 143 are also found predominantly in the
cytoplasm at late times, like ERS 1/TRS 1. This might be important in the packaging of
these proteins in the virion. To date, no MCMV virion components have been identified
with transactivating function. Our laboratory is currently investigating the ability of
pm 142 and pm 143 to be packaged in the virion.
In order to do this, we will be purifying virion particles from glycerol gradients.
These purified virions will be subjected to Western blot analysis using pm !42 and pml43
antisera. If pm l42 and pm!43 do localize to the virion, we will continue our studies by
determining if pm 142 and pm l43 localize to the surface of the viral envelope or reside
within the virion. In order to do this, protease digestion assays will be done using
trypsin. Trypsin treatment of the virion will degrade proteins outside the viral envelope.
Following trypsin treatment, Western blot analyses will be done using pm l42 and pm 143
antisera. If pm l42 and pml43 are located within the virion particle, this will suggest that
they may be tegument proteins. If pm 142 and pm 143 are tegument proteins, they likely
transactivate the MCMV major immediate early enhancer and promoter (MIEPE)
immediately following viral entry into the host cell.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

106

Alternatively, it is possible that there may be some low level expression o f IE 1
and IE3 protein at early and late times. In a time course experiment, EE1 and IE3 are
expressed most abundantly at 2 hours post infection. However, these proteins remain
throughout the course o f the viral infection at low levels. The IE1 and IE3 proteins
however are not detectable under conditions in which only early genes are expressed.
This suggests that the IE I and IE3 protein is relatively stable. Therefore, it is not likely
that pm 142 and pm 143 transactivate the MIEPE at early times.
In order to determine if pm!42 and pml43 transactivate the MIEPE, we varied the
amount of l42/l43pCDN A transfected with the MIEP-reporter construct (Fig. 20).
When 1 pg of 142/143pCDNA effector plasmid was cotransfected with Ipg of target
plasmid MIEP-CAT (E:T ratio of 1:1), no transactivation above basal levels was
observed. Transactivation was observed (3-4 fold above basal levels) when 2 pg or 3 pg
o f 142/l43pCDNA effector plasmid was cotransfected with I pg of target plasmid MIEPCAT (E:T ratio o f 2:1 or 3:1). The effector to target ratio o f 1:1 is what likely occurs
during a natural infection, not 2:1 or 3:1 ratio, since there is one copy o f the iel/ie3 gene
locus per m !42/m l43 gene locus in an infected cell. Therefore, it is possible that these
findings were not biologically relevant and do not occur during a normal infection. On
the other hand, if pm 142 and pm 143 are packaged in the virion, it is likely that a target
ratio o f 1:1 would not be taking place during a natural infection. Depending on how
much pm l42/pm l43 is packaged in the tegument, ratios o f at least 2:1 or 3:1 could be
reached, thus making these findings more indicative o f what takes place during a natural
infection.
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We also found that pm l42 and pm l43 have additive effects with IE1 and IE3 in
the activation o f the MIEP (Fig. 25). These results were not surprising because the other
immediate early proteins (IE1 and IE3) have independent effects on the activation o f the
MIEP and when these proteins are introduced collectively, their effect on the MIEP is
additive (Fig. 3). The potential mechanism by which these proteins could transactivate
the MIEP will be discussed later.

Failure o f the 142pCDNA and 143pCDNA expression vectors to reproduce the
results found with 142/143pCDNA. Proteins expressed from 142/143pCDNA (which
expresses pm l42 and pml43) were able to transactivate the MIEP. However when the
m l42 expression vector (142pCDNA) and the m l43 expression vector (143pCDNA)
were cotransfected, they failed to reproduce the results found with 142/143pCDNA (Fig.
21). We believe that the phenomenon o f squelching may account for the discrepancies in
our transfection experiments. There is precedence that squelching occurs when
transcriptional transactivators are overexpressed in transfection assays. For example,
when the acidic domain of the HSV-1 regulatory protein VP 16 (virion protein 16) was
overexpressed in transfection assays, the transactivating ability of this protein was
inhibited (Pfitzner et al., 1993). More specifically, the overexpressed VP 16 protein
interacted with and sequestered a basal transcription factor that was required for
transcription. Other overexpressed transcriptional transactivators interact with and
squelch common transcriptional transactivators like SP1 (Pfitzner et al., 1993).
High levels o f pmI42 and pm l43 protein were expressed from the plasmids
142pCDNA and 143pCDNA, respectively when compared to proteins expressed from
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142/143pCDNA (Fig. 22). This was because the expression from 142pCDNA and
143pCDNA was driven by the strong HCMV enhancer located directly upstream of the
m l42 and m l43 genes. A low level o f expression of pmI42 and pm I43 from the
!42/143pCDNA expression vector, was likely driven by the m l42 and m l43 native
promoter, which is relatively weak. It is likely that the high levels o f pm 142 and pm 143
expressed from 142pCDNA and 143pCDNA, respectively cause transcriptional
interference by sequestering a transcription factor, coactivator or protein within the basal
transcription factor complex which is present in limiting quantities. In the absence of this
component, expression from the reporter plasmid is inhibited. We can determine if
squelching is taking place with these constructs by transfecting cells with the
142/143pCDNA and MIEP-CAT. If the levels o f CAT activity decrease when
142pCDNA or 143pCDNA is titrated in, this would suggest that squelching is taking
place.
It is also possible that because o f the high level o f protein expression from
142pCDNA and 143pCDNA, pm l42 and pml43 do not localize to the correct cellular
compartment. If pml42 and pm 143 do not localize properly, they will not be able to
function properly. It is also possible that an alternate transcript may be expressed from
!42/143pCDNA that is absent in 142pCDNA and 143pCDNA, which may be important
in transactivation. In addition to the m l42 and ml43 transcripts, an additional transcript
is expressed from this region (designated ml42c). Sequences from m l42c are contained
within !42/143pCDNA. If a proteins expressed from m l42c are involved in
transactivation, 142pCDNA and 143pCDNA combined would not be able to reproduce
the results found with 142/143pCDNA. Lastly, a negative feedback loop mechanism
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may be involved, such that if the level o f pm l42 and pml43 surpasses a certain
threshold, the activity of these proteins will be shut off.
In the future, expression vectors containing m l42 or ml43 und. er the control o f its
native promoter will be made. These constructs will be tested in transiient assays in a
similar fashion as !42pCDNA and 143pCDNA. The constructs containing m l42 or
m l43 under the control of its native promoter will allow the function oof pm l42 or pm l43
to be determined while maintaining protein levels that are biologically relevant.

Transactivation of the e l promoter by pml42 a n d pm l43
We determined if pm 142 and pm 143 were able to transactivate an early gene that
is involved in viral DNA replication. We tested the ability of pm l42 amd pm l43 to
transactivate the el promoter (M l 12-113). The el gene is homologous to the HCMV
UL112-113, which is required for HCMV ori-lyt dependent DNA replication. We found
that the pm l42 and pml43 proteins were not able to transactivate the eel promoter alone
(Fig. 26). However in the presence o f IE1 and IE3, cooperative activity was observed
(Fig. 27). In the presence of 1 pg o f 142/143pCDNA, transactivation tiby IEI/IE3
increased from 30 fold to 50 fold above basal levels. When the am ount o f
142/143pCDNA was increased to 3 pg, transactivation by IE1/IE3 increased to at least
100 fold above basal levels. This was the first demonstration that otherr MCMV viral
proteins assist in IE1/IE3 mediated transactivation o f the el promoter 0(M112-112) or any
other promoter.
HCMV IRSl/TRSl acts synergistically with HCMV IE1 and LE2 to transactivate
the UL112-113 promoter. Once more in these studies, pm 142 and pm! 143 are similar to
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IRS 1/TRS 1. The m l42 and ml43 gene products and IE1/IE3, act cooperatively to
activate the e l promoter (M l 12-113), which is involved in viral DNA replication. The
pm 142 and pm 143 proteins may help to activate the expression o f the other replication
fork proteins as well. Like in HCMV, MCMV regulatory proteins are probably more
efficient at activating viral replication fork proteins when present collectively.
As stated previously, transactivation by IEI/IE3 was increased in the presence of
proteins expressed from 142/l43pCDNA (Fig. 27). However, when the IE1 and IE3
expression vector was cotransfected with 142pCDNA and 143pCDNA, cooperative
activity did not occur (Fig. 28). This is likely due to squelching, since very high levels of
pm l42 and pm l43 were expressed from 142pCDNA and 143pCDNA under these
conditions (Fig. 29). It is also possible that improper protein localization may occur due
to the high protein levels expressed from 142pCDNA and 143pCDNA, or a negative
feedback control mechanism is being used. In the future, these experiments will be
repeated using constructs expressing the m l42 or m l43 protein under the control o f its
native promoter. The m l42 and m l43 native promoters are not as strong as the HCMV
MIEP, and therefore the squelching phenomenon will probably be prevented.
The cooperative results with IE1/IE3 and m l42/m l43 can be interpreted in
different ways, since the effector plasmid (pIEl 11 which expresses IE1 and IE3) used in
the experiment is under the control of the MIEP, and the IE3 protein represses expression
from this promoter (Messerle, 1992). The pm l42 and pm l43 proteins have also been
shown to regulate this promoter. Furthermore, the m l 42 and m l43 expression vectors
contain the HCMV MIEP that may be regulated by MCMV IE1/IE3 proteins and pm l42
and pm l43 as well. Therefore, it is difficult to know for sure if the cooperation occurs

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Ill

because pm l42 and pm 143 are increasing the expression o f EE1 and IE3 by activating the
MIEPE, or if the effect of the pml42 and pm!43 proteins is more directly related to the
el promoter. In the future, these experiments will be repeated with the effector plasmids
cloned under the control o f a heterologous promoter like the SV40 promoter.

Potential Mechanism of pm l42 and pml43 Gene Regulation
There are several potential mechanisms by which pm 142 and pm 143 could
regulate the MIEPE (M l22-123) and the el (M l 12-1123) promoters. These proteins
could 1) activate the expression of a cellular transcription factor, 2) bind directly to viral
promoter or enhancer regions 3) interact with transcription factors or components o f the
basal transcription factor complex to facilitate transcription, or 4) bind to an inhibitor o f a
transcription factor.
The pm 142 and pm 143 proteins could activate the expression of a cellular factor
that is important in the transactivation of viral promoters. The MCMV MIEPE and the
Ml 12/113 promoter have very complex promoter/enhancer regions containing several
cellular transcription factor binding sites. In HCMV, IE 1 and IE2 proteins can regulate
the expression o f cellular genes involved in cell growth or cell cycle control. HCMV IE 1
and IE2 can transactivate the c-fos, c-myc and hsp70 promoters, thus allowing the
conditions within the cell to become more favorable for a permissive viral infection
(Hagemeier et al., 1999). A similar scenario could be taking place with the pm l42 and
pml43. The pm l42 and pm!43 proteins transactivate the promoter of a cellular factor
like c-fos, which then binds to viral promoter/enhancer regions to activate viral gene
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expression. The pm 142 and pm 143 could also activate cellular factors by other
mechanisms such as effects on phosphorylation state o f these proteins.
Proteins pm l42 and pml43 could directly bind DNA promoter/enhancer regions
to regulate cellular and viral genes. The HCMV immediate early protein IE2, directly
binds to DNA to autoregulate its own expression. HCMV IE2 binds to a region in the
promoter referred to as the crs (cis repression sequence) (Lang and Stamminger, 1993)
and thereby interferes with the formation o f the preinitiation complex (Wu et al., 1993).
HCMV IE2 also binds to elements within the promoter of the HCMV early UL112-113
gene. It is possible that pm 142 and pm 143 could bind to cellular and viral promoters
directly, to activate viral gene expression.
It is also possible that pm l42 and pml43 could interact with components o f the
basal transcription factor complex or other transcription factors to facilitate the
transcription o f the cellular and viral genes. The HCMV IE2 protein has been shown to
interact with several cellular transcription factors. The HCMV IE2 protein can bind to
cellular transcription factors E2F-1, SP-1, TEF-1 and CTF-1 (Fumari et al, 1993; Lukac
et al., 1994). HCMV IE2 can also interact with the TATA binding protein, which is a
component o f the basal transcription factor complex TFIID (Jupp et al., 1993). Therefore
pm l42 and pm l43 could regulate cellular and viral promoters by protein/protein
interactions with a transcription factor or component o f the basal transcription factor
complex.
I believe that pm 142 and pm 143 regulate viral promoters by protein/protein
interactions with a transcription factor or component o f the basal transcription factor
complex. The interactions between these proteins could enhance the function o f TFIID,
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by making TFIID more efficient or promoting the establishment o f the preinitiation
complex. Since squelching likely occurs when pm l42 and pm l43 are over expressed,
this suggests that these proteins are able to complex with other factors that are important
in the transactivation o f the MIEPE and the e l promoter. Also, pm l42 and pml43 were
not able to transactivate the el promoter alone, but were able to cooperate with IE1 and
IE3. This suggests that protein-protein interactions are taking place.
To elucidate between the possible mechanisms in which pm 142 and pm 143 may
regulate gene expression, several experiments can be done. In order to determine if
pm l42/pm l43 binds to a certain viral or cellular promoter, Dnasel footprinting can be
done. In this case, an end labeled probe containing a viral or cellular promoter sequence
is incubated with pm l42/pm l43 (generated by vitro transcription/translation) to allow the
formation of protein-DNA complexes. The protein-DNA complex is then exposed to
Dnasel and electrophoresed. If pm 142/pm 143 binds to the DNA, the DNA will be
protected in this region. The exact sequence o f protein binding can also be determined
with this method.
Electrophoretic mobility shift assays (EMSA) can also be used to determine if
pm 142 and pm 143 bind to DNA directly. In this case, promoter sequences are labeled
and used as probe. This probe is then incubated with in vitro translated pm 142 and
pm 143. If the pm 142 and/or pm 143 protein interacts with the labeled probe, there will be
a retardation in the migration o f the labeled probe upon electrophoresis compared to
control samples. If there is evidence that pm l42 and pm l43 bind to the promoter
sequence, more elaborate EMSA experiments can be done using 1) pm l42 or pm l43
antibody to confirm the presence of pm 142 or pm 143 in the protein-DNA complex by
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supershift 2) specific or nonspecific DNA competitors to determine the binding affinities
o f the proteins or 3) mutated probes to determine to what sequences pm 142 and pm 143
bind.
In order to determine if pm l42 or pml43 interact with other viral or cellular
transcriptional transactivators, MCMV infected cell lysates can be immunoprecipitated
with pm 142 or pm 143 antibody, and co-precipitating proteins analyzed by Western blot
using an antibody against the potential interacting protein. If there is evidence o f an
interaction, more extensive studies can be done using glutathione -S-transferase (GST)
fusion proteins. The m l42 and m l43 genes can be cloned in frame to GST to generate
GST-ml42 and GST-ml43. GST-ml42 or GST-ml43 will then be immobilized on
glutathione-agarose beads, and incubated with the labeled in vitro translated potentially
interacting protein. The complexes will be run on an acrylamide gel, the gel dried, and
exposed to xray film. If a band is detected, the labeled protein is likely complexing with
pm l42 and pml43.

Conclusions
We have characterized the expression of the m l42 and m l43 genes and their
products, which are essential for MCMV viral DNA replication. These findings were
significant because m l42 and m l43 are novel immediate early genes and prior to these
studies only three MCMV IE genes had been characterized. It was shown the pm 142 and
pm 143 act cooperative with IE I and IE3 to transactivate an early promoter. This was the
first demonstration o f a MCMV protein assisting IE1/IE3 mediated transaction.
However, since m l42 and m l43 are essential for viral replication in fibroblasts, they
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likely have other functions that deem them necessary for viral replication. Therefore,
more study needs to be done on the m l42-m l43 genes to elucidate other roles these
proteins may play in viral infection.
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CHAPTER VI
FUTURE DIRECTIONS
Since pm l42 and pml43 are able to transactivate the same genes as MCMV IE1
and IE3, pm l42/pm !43 probably have an additional function that deems them essential
for viral replication. In order to determine what this function is, fibroblast cell lines
stably transfected with ml42 and m l43 genes will be made. Next mutant viruses, deleted
o f m l42 and m l43 will be generated using these stably transfected cell lines to
complement mutant virus growth. After the m l42-m l43 mutant viruses have been
generated, they will be grown on normal fibroblast cells under condition in which IE, E
or L genes are expressed. These cells will then be harvested and total RNA will be
isolated. The RNA will be converted to cDNA. The cDNA will be labeled and used to
probe microarrays containing MCMV genes. The results o f the microarray analysis will
determine where in the viral replication cycle m l42 and m l43 are necessary; IE, E or L
times. These studies will give further insight as to the function o f these genes. Similar
experiments will be done after growing the m l42-m l43 mutant viruses on different cell
lines, like macrophages. This will allow us to determine if these genes are important in a
specific cell type that is involved in the pathogenesis o f the virus.
In addition, promoter deletion analyses and gel shift analysis will be done to
determine to which promoter sequences pm 142 and pm l43 may bind. In parallel, single
site and deletion mutations will be made within the m l42 and m l43 gene to determine
which motifs are important in promoter activation. These mutants can also be tested with
respect to DNA binding and protein-protein interactions.
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